þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
75-3108137
|
State of Incorporation
|
|
IRS Employer Identification No.
|
|
|
|
11825 N. Pennsylvania Street
|
|
|
Carmel, Indiana 46032
|
|
(317) 817-6100
|
Address of principal executive offices
|
|
Telephone
|
PART I - FINANCIAL INFORMATION
|
Page
|
|
|
|
|
Item 1.
|
Financial Statements (unaudited)
|
|
|
|
|
|
||
|
||
|
||
|
||
|
||
|
||
|
|
|
Item 2.
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
|
|
|
PART II - OTHER INFORMATION
|
|
|
|
|
|
Item 1.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 6.
|
|
June 30,
2017 |
|
December 31,
2016 |
||||
|
|
|
|
||||
Investments:
|
|
|
|
||||
Fixed maturities, available for sale, at fair value (amortized cost: June 30, 2017 - $20,128.9; December 31, 2016 - $19,803.1)
|
$
|
22,071.4
|
|
|
$
|
21,096.2
|
|
Equity securities at fair value (cost: June 30, 2017 - $598.2; December 31, 2016 - $580.7)
|
622.6
|
|
|
584.2
|
|
||
Mortgage loans
|
1,734.7
|
|
|
1,768.0
|
|
||
Policy loans
|
112.1
|
|
|
112.0
|
|
||
Trading securities
|
308.0
|
|
|
363.4
|
|
||
Investments held by variable interest entities
|
1,309.6
|
|
|
1,724.3
|
|
||
Other invested assets
|
722.6
|
|
|
589.5
|
|
||
Total investments
|
26,881.0
|
|
|
26,237.6
|
|
||
Cash and cash equivalents - unrestricted
|
548.8
|
|
|
478.9
|
|
||
Cash and cash equivalents held by variable interest entities
|
391.1
|
|
|
189.3
|
|
||
Accrued investment income
|
240.9
|
|
|
239.6
|
|
||
Present value of future profits
|
377.8
|
|
|
401.8
|
|
||
Deferred acquisition costs
|
1,012.4
|
|
|
1,044.7
|
|
||
Reinsurance receivables
|
2,217.9
|
|
|
2,260.4
|
|
||
Income tax assets, net
|
594.2
|
|
|
789.7
|
|
||
Assets held in separate accounts
|
4.7
|
|
|
4.7
|
|
||
Other assets
|
573.0
|
|
|
328.5
|
|
||
Total assets
|
$
|
32,841.8
|
|
|
$
|
31,975.2
|
|
|
June 30,
2017 |
|
December 31,
2016 |
||||
|
|
|
|
||||
Liabilities:
|
|
|
|
||||
Liabilities for insurance products:
|
|
|
|
||||
Policyholder account balances
|
$
|
11,037.3
|
|
|
$
|
10,912.7
|
|
Future policy benefits
|
11,271.7
|
|
|
10,953.3
|
|
||
Liability for policy and contract claims
|
506.3
|
|
|
500.6
|
|
||
Unearned and advanced premiums
|
282.5
|
|
|
282.5
|
|
||
Liabilities related to separate accounts
|
4.7
|
|
|
4.7
|
|
||
Other liabilities
|
866.5
|
|
|
611.4
|
|
||
Investment borrowings
|
1,647.0
|
|
|
1,647.4
|
|
||
Borrowings related to variable interest entities
|
1,532.6
|
|
|
1,662.8
|
|
||
Notes payable – direct corporate obligations
|
913.9
|
|
|
912.9
|
|
||
Total liabilities
|
28,062.5
|
|
|
27,488.3
|
|
||
Commitments and Contingencies
|
|
|
|
|
|
||
Shareholders' equity:
|
|
|
|
|
|
||
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: June 30, 2017 – 169,018,890; December 31, 2016 – 173,753,614)
|
1.7
|
|
|
1.7
|
|
||
Additional paid-in capital
|
3,116.7
|
|
|
3,212.1
|
|
||
Accumulated other comprehensive income
|
894.5
|
|
|
622.4
|
|
||
Retained earnings
|
766.4
|
|
|
650.7
|
|
||
Total shareholders' equity
|
4,779.3
|
|
|
4,486.9
|
|
||
Total liabilities and shareholders' equity
|
$
|
32,841.8
|
|
|
$
|
31,975.2
|
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
|
June 30,
|
|
June 30,
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
|
||||||||
Insurance policy income
|
|
$
|
664.1
|
|
|
$
|
653.6
|
|
|
$
|
1,327.9
|
|
|
$
|
1,298.0
|
|
Net investment income:
|
|
|
|
|
|
|
|
|
|
|
||||||
General account assets
|
|
322.4
|
|
|
295.8
|
|
|
634.4
|
|
|
586.8
|
|
||||
Policyholder and other special-purpose portfolios
|
|
43.9
|
|
|
27.9
|
|
|
119.1
|
|
|
39.6
|
|
||||
Realized investment gains (losses):
|
|
|
|
|
|
|
|
|
|
|
||||||
Net realized investment gains (losses), excluding impairment losses
|
|
24.0
|
|
|
33.5
|
|
|
40.3
|
|
|
42.6
|
|
||||
Other-than-temporary impairments:
|
|
|
|
|
|
|
|
|
||||||||
Total other-than-temporary impairment losses
|
|
(4.2
|
)
|
|
(13.6
|
)
|
|
(12.6
|
)
|
|
(23.6
|
)
|
||||
Portion of other-than-temporary impairment losses recognized in accumulated other comprehensive income
|
|
(.9
|
)
|
|
—
|
|
|
(.9
|
)
|
|
—
|
|
||||
Net impairment losses recognized
|
|
(5.1
|
)
|
|
(13.6
|
)
|
|
(13.5
|
)
|
|
(23.6
|
)
|
||||
Loss on dissolution of variable interest entities
|
|
(3.7
|
)
|
|
(7.3
|
)
|
|
(3.7
|
)
|
|
(7.3
|
)
|
||||
Total realized gains
|
|
15.2
|
|
|
12.6
|
|
|
23.1
|
|
|
11.7
|
|
||||
Fee revenue and other income
|
|
11.5
|
|
|
14.0
|
|
|
23.3
|
|
|
28.2
|
|
||||
Total revenues
|
|
1,057.1
|
|
|
1,003.9
|
|
|
2,127.8
|
|
|
1,964.3
|
|
||||
Benefits and expenses:
|
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
|
634.2
|
|
|
632.4
|
|
|
1,303.5
|
|
|
1,251.4
|
|
||||
Interest expense
|
|
31.4
|
|
|
28.9
|
|
|
62.2
|
|
|
56.6
|
|
||||
Amortization
|
|
59.6
|
|
|
54.8
|
|
|
123.1
|
|
|
116.9
|
|
||||
Other operating costs and expenses
|
|
203.4
|
|
|
205.1
|
|
|
413.8
|
|
|
416.2
|
|
||||
Total benefits and expenses
|
|
928.6
|
|
|
921.2
|
|
|
1,902.6
|
|
|
1,841.1
|
|
||||
Income before income taxes
|
|
128.5
|
|
|
82.7
|
|
|
225.2
|
|
|
123.2
|
|
||||
Income tax expense (benefit):
|
|
|
|
|
|
|
|
|
||||||||
Tax expense on period income
|
|
45.1
|
|
|
29.8
|
|
|
79.5
|
|
|
44.8
|
|
||||
Valuation allowance for deferred tax assets
|
|
—
|
|
|
(7.0
|
)
|
|
—
|
|
|
(27.0
|
)
|
||||
Net income
|
|
$
|
83.4
|
|
|
$
|
59.9
|
|
|
$
|
145.7
|
|
|
$
|
105.4
|
|
Earnings per common share:
|
|
|
|
|
|
|
|
|
||||||||
Basic:
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares outstanding
|
|
170,556,000
|
|
|
178,323,000
|
|
|
171,994,000
|
|
|
179,337,000
|
|
||||
Net income
|
|
$
|
.49
|
|
|
$
|
.34
|
|
|
$
|
.85
|
|
|
$
|
.59
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|||||||
Weighted average shares outstanding
|
|
172,352,000
|
|
|
180,267,000
|
|
|
173,708,000
|
|
|
181,198,000
|
|
||||
Net income
|
|
$
|
.48
|
|
|
$
|
.33
|
|
|
$
|
.84
|
|
|
$
|
.58
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Net income
|
$
|
83.4
|
|
|
$
|
59.9
|
|
|
$
|
145.7
|
|
|
$
|
105.4
|
|
Other comprehensive income, before tax:
|
|
|
|
|
|
|
|
||||||||
Unrealized gains for the period
|
457.8
|
|
|
669.8
|
|
|
673.6
|
|
|
1,100.9
|
|
||||
Adjustment to present value of future profits and deferred acquisition costs
|
(31.3
|
)
|
|
(63.1
|
)
|
|
(23.5
|
)
|
|
(108.3
|
)
|
||||
Amount related to premium deficiencies assuming the net unrealized gains (losses) had been realized
|
(160.0
|
)
|
|
(242.6
|
)
|
|
(212.0
|
)
|
|
(410.6
|
)
|
||||
Reclassification adjustments:
|
|
|
|
|
|
|
|
||||||||
For net realized investment (gains) losses included in net income
|
(11.2
|
)
|
|
(4.7
|
)
|
|
(16.3
|
)
|
|
(9.6
|
)
|
||||
For amortization of the present value of future profits and deferred acquisition costs related to net realized investment gains (losses) included in net income
|
.3
|
|
|
.6
|
|
|
.3
|
|
|
.7
|
|
||||
Unrealized gains on investments
|
255.6
|
|
|
360.0
|
|
|
422.1
|
|
|
573.1
|
|
||||
Change related to deferred compensation plan
|
—
|
|
|
8.0
|
|
|
—
|
|
|
8.6
|
|
||||
Other comprehensive income before tax
|
255.6
|
|
|
368.0
|
|
|
422.1
|
|
|
581.7
|
|
||||
Income tax expense related to items of accumulated other comprehensive income
|
(90.7
|
)
|
|
(130.7
|
)
|
|
(150.0
|
)
|
|
(206.7
|
)
|
||||
Other comprehensive income, net of tax
|
164.9
|
|
|
237.3
|
|
|
272.1
|
|
|
375.0
|
|
||||
Comprehensive income
|
$
|
248.3
|
|
|
$
|
297.2
|
|
|
$
|
417.8
|
|
|
$
|
480.4
|
|
|
Common stock and
additional
paid-in capital
|
|
Accumulated other
comprehensive income
|
|
Retained earnings
|
|
Total
|
||||||||
Balance, December 31, 2015
|
$
|
3,388.6
|
|
|
$
|
402.8
|
|
|
$
|
347.1
|
|
|
$
|
4,138.5
|
|
Net income
|
—
|
|
|
—
|
|
|
105.4
|
|
|
105.4
|
|
||||
Change in unrealized appreciation (depreciation) of investments and other (net of applicable income tax expense of $206.3)
|
—
|
|
|
374.2
|
|
|
—
|
|
|
374.2
|
|
||||
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense of $.4)
|
—
|
|
|
.8
|
|
|
—
|
|
|
.8
|
|
||||
Cost of common stock repurchased
|
(151.0
|
)
|
|
—
|
|
|
—
|
|
|
(151.0
|
)
|
||||
Dividends on common stock
|
—
|
|
|
—
|
|
|
(26.9
|
)
|
|
(26.9
|
)
|
||||
Stock options, restricted stock and performance units
|
15.2
|
|
|
—
|
|
|
—
|
|
|
15.2
|
|
||||
Balance, June 30, 2016
|
$
|
3,252.8
|
|
|
$
|
777.8
|
|
|
$
|
425.6
|
|
|
$
|
4,456.2
|
|
|
|
|
|
|
|
|
|
||||||||
Balance, December 31, 2016
|
$
|
3,213.8
|
|
|
$
|
622.4
|
|
|
$
|
650.7
|
|
|
$
|
4,486.9
|
|
Cumulative effect of accounting change
|
.9
|
|
|
—
|
|
|
(.6
|
)
|
|
.3
|
|
||||
Net income
|
—
|
|
|
—
|
|
|
145.7
|
|
|
145.7
|
|
||||
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense of $148.5)
|
—
|
|
|
269.4
|
|
|
—
|
|
|
269.4
|
|
||||
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense of $1.5)
|
—
|
|
|
2.7
|
|
|
—
|
|
|
2.7
|
|
||||
Cost of common stock repurchased
|
(111.9
|
)
|
|
—
|
|
|
—
|
|
|
(111.9
|
)
|
||||
Dividends on common stock
|
—
|
|
|
—
|
|
|
(29.4
|
)
|
|
(29.4
|
)
|
||||
Stock options, restricted stock and performance units
|
15.6
|
|
|
—
|
|
|
—
|
|
|
15.6
|
|
||||
Balance, June 30, 2017
|
$
|
3,118.4
|
|
|
$
|
894.5
|
|
|
$
|
766.4
|
|
|
$
|
4,779.3
|
|
|
Six months ended
|
||||||
|
June 30,
|
||||||
|
2017
|
|
2016
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Insurance policy income
|
$
|
1,257.2
|
|
|
$
|
1,227.6
|
|
Net investment income
|
618.7
|
|
|
600.5
|
|
||
Fee revenue and other income
|
23.3
|
|
|
28.2
|
|
||
Insurance policy benefits
|
(1,007.9
|
)
|
|
(967.4
|
)
|
||
Interest expense
|
(61.0
|
)
|
|
(48.7
|
)
|
||
Deferrable policy acquisition costs
|
(126.6
|
)
|
|
(118.8
|
)
|
||
Other operating costs
|
(391.5
|
)
|
|
(378.2
|
)
|
||
Income taxes
|
(33.7
|
)
|
|
(3.5
|
)
|
||
Net cash from operating activities
|
278.5
|
|
|
339.7
|
|
||
Cash flows from investing activities:
|
|
|
|
|
|
||
Sales of investments
|
891.1
|
|
|
1,702.0
|
|
||
Maturities and redemptions of investments
|
1,808.5
|
|
|
992.4
|
|
||
Purchases of investments
|
(2,584.8
|
)
|
|
(3,099.5
|
)
|
||
Net sales (purchases) of trading securities
|
74.8
|
|
|
(15.9
|
)
|
||
Change in cash and cash equivalents held by variable interest entities
|
(201.8
|
)
|
|
204.4
|
|
||
Other
|
(15.7
|
)
|
|
(10.5
|
)
|
||
Net cash used by investing activities
|
(27.9
|
)
|
|
(227.1
|
)
|
||
Cash flows from financing activities:
|
|
|
|
|
|
||
Issuance of common stock
|
5.4
|
|
|
3.7
|
|
||
Payments to repurchase common stock
|
(111.1
|
)
|
|
(148.9
|
)
|
||
Common stock dividends paid
|
(29.3
|
)
|
|
(27.0
|
)
|
||
Amounts received for deposit products
|
727.8
|
|
|
649.3
|
|
||
Withdrawals from deposit products
|
(638.9
|
)
|
|
(617.6
|
)
|
||
Issuance of investment borrowings:
|
|
|
|
||||
Federal Home Loan Bank
|
132.0
|
|
|
—
|
|
||
Related to variable interest entities
|
30.7
|
|
|
479.9
|
|
||
Payments on investment borrowings:
|
|
|
|
||||
Federal Home Loan Bank
|
(132.4
|
)
|
|
(.3
|
)
|
||
Related to variable interest entities
|
(164.9
|
)
|
|
(446.8
|
)
|
||
Net cash used by financing activities
|
(180.7
|
)
|
|
(107.7
|
)
|
||
Net increase in cash and cash equivalents
|
69.9
|
|
|
4.9
|
|
||
Cash and cash equivalents, beginning of period
|
478.9
|
|
|
432.3
|
|
||
Cash and cash equivalents, end of period
|
$
|
548.8
|
|
|
$
|
437.2
|
|
|
June 30,
2017 |
|
December 31,
2016 |
||||
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment loss has been recognized
|
$
|
3.5
|
|
|
$
|
(1.1
|
)
|
Net unrealized gains on all other investments
|
1,964.6
|
|
|
1,311.9
|
|
||
Adjustment to present value of future profits (a)
|
(101.8
|
)
|
|
(106.2
|
)
|
||
Adjustment to deferred acquisition costs
|
(287.7
|
)
|
|
(223.5
|
)
|
||
Adjustment to insurance liabilities
|
(188.9
|
)
|
|
(13.5
|
)
|
||
Deferred income tax liabilities
|
(495.2
|
)
|
|
(345.2
|
)
|
||
Accumulated other comprehensive income
|
$
|
894.5
|
|
|
$
|
622.4
|
|
(a)
|
The present value of future profits is the value assigned to the right to receive future cash flows from contracts existing at September 10, 2003, the date Conseco, Inc., an Indiana corporation, emerged from bankruptcy.
|
|
Amortized cost
|
|
Gross unrealized gains
|
|
Gross unrealized losses
|
|
Estimated fair value
|
|
Other-than-temporary impairments included in accumulated other comprehensive income
|
||||||||||
Corporate securities
|
$
|
12,960.6
|
|
|
$
|
1,508.5
|
|
|
$
|
(50.1
|
)
|
|
$
|
14,419.0
|
|
|
$
|
(3.6
|
)
|
United States Treasury securities and obligations of United States government corporations and agencies
|
174.4
|
|
|
27.8
|
|
|
—
|
|
|
202.2
|
|
|
—
|
|
|||||
States and political subdivisions
|
1,856.0
|
|
|
217.2
|
|
|
(2.5
|
)
|
|
2,070.7
|
|
|
—
|
|
|||||
Debt securities issued by foreign governments
|
55.3
|
|
|
1.7
|
|
|
(.1
|
)
|
|
56.9
|
|
|
—
|
|
|||||
Asset-backed securities
|
2,698.3
|
|
|
149.0
|
|
|
(3.9
|
)
|
|
2,843.4
|
|
|
—
|
|
|||||
Collateralized debt obligations
|
226.1
|
|
|
1.3
|
|
|
—
|
|
|
227.4
|
|
|
—
|
|
|||||
Commercial mortgage-backed securities
|
1,364.7
|
|
|
37.5
|
|
|
(14.8
|
)
|
|
1,387.4
|
|
|
—
|
|
|||||
Mortgage pass-through securities
|
2.1
|
|
|
.2
|
|
|
—
|
|
|
2.3
|
|
|
—
|
|
|||||
Collateralized mortgage obligations
|
791.4
|
|
|
71.9
|
|
|
(1.2
|
)
|
|
862.1
|
|
|
(1.2
|
)
|
|||||
Total fixed maturities, available for sale
|
$
|
20,128.9
|
|
|
$
|
2,015.1
|
|
|
$
|
(72.6
|
)
|
|
$
|
22,071.4
|
|
|
$
|
(4.8
|
)
|
Equity securities
|
$
|
598.2
|
|
|
$
|
27.1
|
|
|
$
|
(2.7
|
)
|
|
$
|
622.6
|
|
|
|
|
Amortized
cost
|
|
Estimated
fair
value
|
||||
|
(Dollars in millions)
|
||||||
Due in one year or less
|
$
|
409.8
|
|
|
$
|
417.1
|
|
Due after one year through five years
|
2,126.4
|
|
|
2,269.8
|
|
||
Due after five years through ten years
|
1,549.7
|
|
|
1,646.6
|
|
||
Due after ten years
|
10,960.4
|
|
|
12,415.3
|
|
||
Subtotal
|
15,046.3
|
|
|
16,748.8
|
|
||
Structured securities
|
5,082.6
|
|
|
5,322.6
|
|
||
Total fixed maturities, available for sale
|
$
|
20,128.9
|
|
|
$
|
22,071.4
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Fixed maturity securities, available for sale:
|
|
|
|
|
|
|
|
||||||||
Gross realized gains on sale
|
$
|
21.1
|
|
|
$
|
21.3
|
|
|
$
|
28.1
|
|
|
$
|
119.8
|
|
Gross realized losses on sale
|
(5.2
|
)
|
|
(.6
|
)
|
|
(7.9
|
)
|
|
(81.6
|
)
|
||||
Impairments:
|
|
|
|
|
|
|
|
||||||||
Total other-than-temporary impairment losses
|
(3.6
|
)
|
|
—
|
|
|
(6.8
|
)
|
|
(6.3
|
)
|
||||
Other-than-temporary impairment losses recognized in accumulated other comprehensive income
|
(.9
|
)
|
|
—
|
|
|
(.9
|
)
|
|
—
|
|
||||
Net impairment losses recognized
|
(4.5
|
)
|
|
—
|
|
|
(7.7
|
)
|
|
(6.3
|
)
|
||||
Net realized investment gains from fixed maturities
|
11.4
|
|
|
20.7
|
|
|
12.5
|
|
|
31.9
|
|
||||
Equity securities
|
—
|
|
|
4.0
|
|
|
1.9
|
|
|
4.1
|
|
||||
Commercial mortgage loans
|
—
|
|
|
—
|
|
|
1.0
|
|
|
—
|
|
||||
Impairments of other investments
|
(.6
|
)
|
|
(13.6
|
)
|
|
(5.8
|
)
|
|
(17.3
|
)
|
||||
Loss on dissolution of variable interest entities
|
(3.7
|
)
|
|
(7.3
|
)
|
|
(3.7
|
)
|
|
(7.3
|
)
|
||||
Other (a)
|
8.1
|
|
|
8.8
|
|
|
17.2
|
|
|
.3
|
|
||||
Net realized investment gains
|
$
|
15.2
|
|
|
$
|
12.6
|
|
|
$
|
23.1
|
|
|
$
|
11.7
|
|
(a)
|
Changes in the estimated fair value of trading securities that we have elected the fair value option (and are still held as of the end of the respective periods) was
$9.9 million
for the
six
months ended
June 30, 2017
. Such amount was insignificant in the
2016
period.
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Credit losses on fixed maturity securities, available for sale, beginning of period
|
$
|
(5.4
|
)
|
|
$
|
(2.6
|
)
|
|
$
|
(5.5
|
)
|
|
$
|
(2.6
|
)
|
Add: credit losses on other-than-temporary impairments not previously recognized
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Less: credit losses on securities sold
|
1.5
|
|
|
—
|
|
|
1.6
|
|
|
—
|
|
||||
Less: credit losses on securities impaired due to intent to sell (a)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Add: credit losses on previously impaired securities
|
(1.0
|
)
|
|
—
|
|
|
(1.0
|
)
|
|
—
|
|
||||
Less: increases in cash flows expected on previously impaired securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Credit losses on fixed maturity securities, available for sale, end of period
|
$
|
(4.9
|
)
|
|
$
|
(2.6
|
)
|
|
$
|
(4.9
|
)
|
|
$
|
(2.6
|
)
|
(a)
|
Represents securities for which the amount previously recognized in accumulated other comprehensive income was recognized in earnings because we intend to sell the security or we more likely than not will be required to sell the security before recovery of its amortized cost basis.
|
|
|
Less than 12 months
|
|
12 months or greater
|
|
Total
|
||||||||||||||||||
Description of securities
|
|
Fair
value
|
|
Unrealized
losses
|
|
Fair
value
|
|
Unrealized
losses
|
|
Fair
value
|
|
Unrealized
losses
|
||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
|
$
|
47.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
47.0
|
|
|
$
|
—
|
|
States and political subdivisions
|
|
68.8
|
|
|
(2.0
|
)
|
|
13.2
|
|
|
(.5
|
)
|
|
82.0
|
|
|
(2.5
|
)
|
||||||
Debt securities issued by foreign governments
|
|
15.7
|
|
|
(.1
|
)
|
|
—
|
|
|
—
|
|
|
15.7
|
|
|
(.1
|
)
|
||||||
Corporate securities
|
|
566.2
|
|
|
(11.7
|
)
|
|
442.8
|
|
|
(38.4
|
)
|
|
1,009.0
|
|
|
(50.1
|
)
|
||||||
Asset-backed securities
|
|
388.6
|
|
|
(2.5
|
)
|
|
83.3
|
|
|
(1.4
|
)
|
|
471.9
|
|
|
(3.9
|
)
|
||||||
Collateralized debt obligations
|
|
30.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
30.5
|
|
|
—
|
|
||||||
Commercial mortgage-backed securities
|
|
381.5
|
|
|
(9.2
|
)
|
|
103.3
|
|
|
(5.6
|
)
|
|
484.8
|
|
|
(14.8
|
)
|
||||||
Collateralized mortgage obligations
|
|
69.3
|
|
|
(.7
|
)
|
|
28.1
|
|
|
(.5
|
)
|
|
97.4
|
|
|
(1.2
|
)
|
||||||
Total fixed maturities, available for sale
|
|
$
|
1,567.6
|
|
|
$
|
(26.2
|
)
|
|
$
|
670.7
|
|
|
$
|
(46.4
|
)
|
|
$
|
2,238.3
|
|
|
$
|
(72.6
|
)
|
Equity securities
|
|
$
|
134.2
|
|
|
$
|
(2.7
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
134.2
|
|
|
$
|
(2.7
|
)
|
|
|
Less than 12 months
|
|
12 months or greater
|
|
Total
|
||||||||||||||||||
Description of securities
|
|
Fair
value
|
|
Unrealized
losses
|
|
Fair
value
|
|
Unrealized
losses
|
|
Fair
value
|
|
Unrealized
losses
|
||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
|
$
|
8.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
8.0
|
|
|
$
|
—
|
|
States and political subdivisions
|
|
176.3
|
|
|
(7.8
|
)
|
|
18.3
|
|
|
(1.8
|
)
|
|
194.6
|
|
|
(9.6
|
)
|
||||||
Debt securities issued by foreign governments
|
|
18.9
|
|
|
(.4
|
)
|
|
—
|
|
|
—
|
|
|
18.9
|
|
|
(.4
|
)
|
||||||
Corporate securities
|
|
1,907.6
|
|
|
(75.5
|
)
|
|
559.6
|
|
|
(63.5
|
)
|
|
2,467.2
|
|
|
(139.0
|
)
|
||||||
Asset-backed securities
|
|
692.9
|
|
|
(8.5
|
)
|
|
262.5
|
|
|
(7.0
|
)
|
|
955.4
|
|
|
(15.5
|
)
|
||||||
Collateralized debt obligations
|
|
38.3
|
|
|
(.1
|
)
|
|
30.8
|
|
|
(.2
|
)
|
|
69.1
|
|
|
(.3
|
)
|
||||||
Commercial mortgage-backed securities
|
|
525.2
|
|
|
(16.6
|
)
|
|
154.0
|
|
|
(11.3
|
)
|
|
679.2
|
|
|
(27.9
|
)
|
||||||
Collateralized mortgage obligations
|
|
73.6
|
|
|
(.6
|
)
|
|
34.6
|
|
|
(1.0
|
)
|
|
108.2
|
|
|
(1.6
|
)
|
||||||
Total fixed maturities, available for sale
|
|
$
|
3,440.8
|
|
|
$
|
(109.5
|
)
|
|
$
|
1,059.8
|
|
|
$
|
(84.8
|
)
|
|
$
|
4,500.6
|
|
|
$
|
(194.3
|
)
|
Equity securities
|
|
$
|
239.4
|
|
|
$
|
(8.0
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
239.4
|
|
|
$
|
(8.0
|
)
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Net income for basic and diluted earnings per share
|
$
|
83.4
|
|
|
$
|
59.9
|
|
|
$
|
145.7
|
|
|
$
|
105.4
|
|
Shares:
|
|
|
|
|
|
|
|
|
|
||||||
Weighted average shares outstanding for basic earnings per share
|
170,556
|
|
|
178,323
|
|
|
171,994
|
|
|
179,337
|
|
||||
Effect of dilutive securities on weighted average shares:
|
|
|
|
|
|
|
|
|
|
||||||
Stock options, restricted stock and performance units
|
1,796
|
|
|
1,944
|
|
|
1,714
|
|
|
1,861
|
|
||||
Weighted average shares outstanding for diluted earnings per share
|
172,352
|
|
|
180,267
|
|
|
173,708
|
|
|
181,198
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Bankers Life:
|
|
|
|
|
|
|
|
||||||||
Insurance policy income:
|
|
|
|
|
|
|
|
||||||||
Annuities
|
$
|
5.8
|
|
|
$
|
5.8
|
|
|
$
|
11.8
|
|
|
$
|
10.6
|
|
Health
|
308.1
|
|
|
311.9
|
|
|
619.7
|
|
|
623.0
|
|
||||
Life
|
105.2
|
|
|
101.9
|
|
|
206.7
|
|
|
199.2
|
|
||||
Net investment income (a)
|
256.9
|
|
|
227.9
|
|
|
529.8
|
|
|
442.1
|
|
||||
Fee revenue and other income (a)
|
10.6
|
|
|
7.3
|
|
|
21.2
|
|
|
13.9
|
|
||||
Total Bankers Life revenues
|
686.6
|
|
|
654.8
|
|
|
1,389.2
|
|
|
1,288.8
|
|
||||
Washington National:
|
|
|
|
|
|
|
|
|
|
||||||
Insurance policy income:
|
|
|
|
|
|
|
|
|
|
||||||
Annuities
|
.5
|
|
|
.6
|
|
|
1.1
|
|
|
1.1
|
|
||||
Health
|
160.1
|
|
|
156.7
|
|
|
319.9
|
|
|
312.2
|
|
||||
Life
|
6.9
|
|
|
6.2
|
|
|
13.6
|
|
|
12.3
|
|
||||
Net investment income (a)
|
66.5
|
|
|
63.6
|
|
|
133.9
|
|
|
124.2
|
|
||||
Fee revenue and other income (a)
|
.2
|
|
|
.3
|
|
|
.5
|
|
|
.6
|
|
||||
Total Washington National revenues
|
234.2
|
|
|
227.4
|
|
|
469.0
|
|
|
450.4
|
|
||||
Colonial Penn:
|
|
|
|
|
|
|
|
|
|
||||||
Insurance policy income:
|
|
|
|
|
|
|
|
|
|
||||||
Health
|
.5
|
|
|
.7
|
|
|
1.1
|
|
|
1.4
|
|
||||
Life
|
72.5
|
|
|
69.8
|
|
|
144.9
|
|
|
138.2
|
|
||||
Net investment income (a)
|
11.2
|
|
|
10.9
|
|
|
22.1
|
|
|
21.9
|
|
||||
Fee revenue and other income (a)
|
.4
|
|
|
.2
|
|
|
.6
|
|
|
.6
|
|
||||
Total Colonial Penn revenues
|
84.6
|
|
|
81.6
|
|
|
168.7
|
|
|
162.1
|
|
||||
Long-term care in run-off:
|
|
|
|
|
|
|
|
||||||||
Insurance policy income - health
|
4.5
|
|
|
—
|
|
|
9.1
|
|
|
—
|
|
||||
Net investment income (a)
|
10.0
|
|
|
—
|
|
|
19.7
|
|
|
—
|
|
||||
Total Long-term care in run-off revenues
|
14.5
|
|
|
—
|
|
|
28.8
|
|
|
—
|
|
||||
Corporate operations:
|
|
|
|
|
|
|
|
|
|
||||||
Net investment income
|
7.4
|
|
|
5.9
|
|
|
17.8
|
|
|
9.9
|
|
||||
Fee and other income
|
2.3
|
|
|
2.6
|
|
|
4.7
|
|
|
5.1
|
|
||||
Total corporate revenues
|
9.7
|
|
|
8.5
|
|
|
22.5
|
|
|
15.0
|
|
||||
Total revenues
|
1,029.6
|
|
|
972.3
|
|
|
2,078.2
|
|
|
1,916.3
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Expenses:
|
|
|
|
|
|
|
|
||||||||
Bankers Life:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
$
|
419.3
|
|
|
$
|
416.8
|
|
|
$
|
870.5
|
|
|
$
|
813.8
|
|
Amortization
|
41.3
|
|
|
40.0
|
|
|
87.6
|
|
|
91.5
|
|
||||
Interest expense on investment borrowings
|
4.8
|
|
|
3.0
|
|
|
9.0
|
|
|
5.9
|
|
||||
Other operating costs and expenses
|
108.6
|
|
|
101.7
|
|
|
219.8
|
|
|
206.7
|
|
||||
Total Bankers Life expenses
|
574.0
|
|
|
561.5
|
|
|
1,186.9
|
|
|
1,117.9
|
|
||||
Washington National:
|
|
|
|
|
|
|
|
|
|
||||||
Insurance policy benefits
|
145.3
|
|
|
144.0
|
|
|
292.0
|
|
|
277.5
|
|
||||
Amortization
|
15.3
|
|
|
15.1
|
|
|
29.6
|
|
|
30.2
|
|
||||
Interest expense on investment borrowings
|
1.5
|
|
|
.8
|
|
|
2.8
|
|
|
1.6
|
|
||||
Other operating costs and expenses
|
48.5
|
|
|
46.0
|
|
|
97.5
|
|
|
93.3
|
|
||||
Total Washington National expenses
|
210.6
|
|
|
205.9
|
|
|
421.9
|
|
|
402.6
|
|
||||
Colonial Penn:
|
|
|
|
|
|
|
|
|
|
||||||
Insurance policy benefits
|
50.4
|
|
|
50.5
|
|
|
103.1
|
|
|
101.0
|
|
||||
Amortization
|
4.0
|
|
|
3.7
|
|
|
8.0
|
|
|
7.6
|
|
||||
Interest expense on investment borrowings
|
.2
|
|
|
.2
|
|
|
.4
|
|
|
.3
|
|
||||
Other operating costs and expenses
|
22.0
|
|
|
24.2
|
|
|
49.5
|
|
|
57.0
|
|
||||
Total Colonial Penn expenses
|
76.6
|
|
|
78.6
|
|
|
161.0
|
|
|
165.9
|
|
||||
Long-term care in run-off:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
12.0
|
|
|
—
|
|
|
25.2
|
|
|
—
|
|
||||
Other operating costs and expenses
|
.8
|
|
|
—
|
|
|
1.5
|
|
|
—
|
|
||||
Total Long-term care in run-off expenses
|
12.8
|
|
|
—
|
|
|
26.7
|
|
|
—
|
|
||||
Corporate operations:
|
|
|
|
|
|
|
|
|
|
||||||
Interest expense on corporate debt
|
11.6
|
|
|
11.4
|
|
|
23.1
|
|
|
22.8
|
|
||||
Other operating costs and expenses
|
22.9
|
|
|
15.5
|
|
|
44.6
|
|
|
30.1
|
|
||||
Total corporate expenses
|
34.5
|
|
|
26.9
|
|
|
67.7
|
|
|
52.9
|
|
||||
Total expenses
|
908.5
|
|
|
872.9
|
|
|
1,864.2
|
|
|
1,739.3
|
|
||||
Pre-tax operating earnings by segment:
|
|
|
|
|
|
|
|
|
|
||||||
Bankers Life
|
112.6
|
|
|
93.3
|
|
|
202.3
|
|
|
170.9
|
|
||||
Washington National
|
23.6
|
|
|
21.5
|
|
|
47.1
|
|
|
47.8
|
|
||||
Colonial Penn
|
8.0
|
|
|
3.0
|
|
|
7.7
|
|
|
(3.8
|
)
|
||||
Long-term care in run-off
|
1.7
|
|
|
—
|
|
|
2.1
|
|
|
—
|
|
||||
Corporate operations
|
(24.8
|
)
|
|
(18.4
|
)
|
|
(45.2
|
)
|
|
(37.9
|
)
|
||||
Pre-tax operating earnings
|
$
|
121.1
|
|
|
$
|
99.4
|
|
|
$
|
214.0
|
|
|
$
|
177.0
|
|
(a)
|
It is not practicable to provide additional components of revenue by product or services.
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Total segment revenues
|
$
|
1,029.6
|
|
|
$
|
972.3
|
|
|
$
|
2,078.2
|
|
|
$
|
1,916.3
|
|
Net realized investment gains
|
15.2
|
|
|
12.6
|
|
|
23.1
|
|
|
11.7
|
|
||||
Revenues related to VIEs
|
12.3
|
|
|
14.0
|
|
|
26.5
|
|
|
26.3
|
|
||||
Fee revenue related to transition and support services agreements
|
—
|
|
|
5.0
|
|
|
—
|
|
|
10.0
|
|
||||
Consolidated revenues
|
1,057.1
|
|
|
1,003.9
|
|
|
2,127.8
|
|
|
1,964.3
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Total segment expenses
|
908.5
|
|
|
872.9
|
|
|
1,864.2
|
|
|
1,739.3
|
|
||||
Insurance policy benefits - fair value changes in embedded derivative liabilities
|
7.2
|
|
|
21.1
|
|
|
12.7
|
|
|
59.1
|
|
||||
Amortization related to fair value changes in embedded derivative liabilities
|
(1.3
|
)
|
|
(4.6
|
)
|
|
(2.4
|
)
|
|
(13.1
|
)
|
||||
Amortization related to net realized investment gains
|
.3
|
|
|
.6
|
|
|
.3
|
|
|
.7
|
|
||||
Expenses related to VIEs
|
13.9
|
|
|
13.9
|
|
|
27.8
|
|
|
26.8
|
|
||||
Fair value changes related to agent deferred compensation plan
|
—
|
|
|
12.3
|
|
|
—
|
|
|
18.3
|
|
||||
Expenses related to transition and support services agreements
|
—
|
|
|
5.0
|
|
|
—
|
|
|
10.0
|
|
||||
Consolidated expenses
|
928.6
|
|
|
921.2
|
|
|
1,902.6
|
|
|
1,841.1
|
|
||||
Income before tax
|
128.5
|
|
|
82.7
|
|
|
225.2
|
|
|
123.2
|
|
||||
Income tax expense (benefit):
|
|
|
|
|
|
|
|
||||||||
Tax expense on period income
|
45.1
|
|
|
29.8
|
|
|
79.5
|
|
|
44.8
|
|
||||
Valuation allowance for deferred tax assets
|
—
|
|
|
(7.0
|
)
|
|
—
|
|
|
(27.0
|
)
|
||||
Net income
|
$
|
83.4
|
|
|
$
|
59.9
|
|
|
$
|
145.7
|
|
|
$
|
105.4
|
|
|
|
Fair value
|
||||||
|
|
June 30,
2017 |
|
December 31, 2016
|
||||
Assets:
|
|
|
|
|
||||
Other invested assets:
|
|
|
|
|
||||
Fixed index call options
|
|
$
|
132.5
|
|
|
$
|
111.9
|
|
Reinsurance receivables
|
|
(2.1
|
)
|
|
(4.2
|
)
|
||
Total assets
|
|
$
|
130.4
|
|
|
$
|
107.7
|
|
Liabilities:
|
|
|
|
|
||||
Future policy benefits:
|
|
|
|
|
||||
Fixed index products
|
|
$
|
1,205.4
|
|
|
$
|
1,092.3
|
|
Total liabilities
|
|
$
|
1,205.4
|
|
|
$
|
1,092.3
|
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
|
June 30,
|
|
June 30,
|
||||||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Net investment income from policyholder and other special-purpose portfolios:
|
|
|
|
|
|
|
|
|
||||||||
Fixed index call options
|
|
$
|
20.3
|
|
|
$
|
2.9
|
|
|
$
|
64.8
|
|
|
$
|
(6.1
|
)
|
Net realized gains (losses):
|
|
|
|
|
|
|
|
|
||||||||
Interest rate futures
|
|
—
|
|
|
(.1
|
)
|
|
—
|
|
|
(1.1
|
)
|
||||
Embedded derivative related to modified coinsurance agreement
|
|
1.4
|
|
|
4.8
|
|
|
2.1
|
|
|
6.6
|
|
||||
Total
|
|
1.4
|
|
|
4.7
|
|
|
2.1
|
|
|
5.5
|
|
||||
Insurance policy benefits:
|
|
|
|
|
|
|
|
|
||||||||
Embedded derivative related to fixed index annuities
|
|
2.5
|
|
|
(16.7
|
)
|
|
4.8
|
|
|
(51.6
|
)
|
||||
Total
|
|
$
|
24.2
|
|
|
$
|
(9.1
|
)
|
|
$
|
71.7
|
|
|
$
|
(52.2
|
)
|
|
|
|
|
|
|
|
|
|
Gross amounts not offset in the balance sheet
|
|
|
||||||||||||||
|
|
|
Gross amounts recognized
|
|
Gross amounts offset in the balance sheet
|
|
Net amounts of assets presented in the balance sheet
|
|
Financial instruments
|
|
Cash collateral received
|
|
Net amount
|
||||||||||||
June 30, 2017:
|
|
|
|||||||||||||||||||||||
|
Fixed index call options
|
|
$
|
132.5
|
|
|
$
|
—
|
|
|
$
|
132.5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
132.5
|
|
December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Fixed index call options
|
|
111.9
|
|
|
—
|
|
|
111.9
|
|
|
—
|
|
|
—
|
|
|
111.9
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Current tax expense
|
$
|
22.0
|
|
|
$
|
.7
|
|
|
$
|
42.6
|
|
|
$
|
4.8
|
|
Deferred tax expense
|
23.1
|
|
|
29.1
|
|
|
36.9
|
|
|
40.0
|
|
||||
Income tax expense calculated based on estimated annual effective tax rate
|
45.1
|
|
|
29.8
|
|
|
79.5
|
|
|
44.8
|
|
||||
Income tax expense on discrete items:
|
|
|
|
|
|
|
|
||||||||
Change in valuation allowance
|
—
|
|
|
(7.0
|
)
|
|
—
|
|
|
(27.0
|
)
|
||||
Total income tax expense (benefit)
|
$
|
45.1
|
|
|
$
|
22.8
|
|
|
$
|
79.5
|
|
|
$
|
17.8
|
|
|
Six months ended
|
||||
|
June 30,
|
||||
|
2017
|
|
2016
|
||
U.S. statutory corporate rate
|
35.0
|
%
|
|
35.0
|
%
|
Non-taxable income and nondeductible benefits, net
|
(1.4
|
)
|
|
(.6
|
)
|
State taxes
|
1.7
|
|
|
2.0
|
|
Estimated annual effective tax rate
|
35.3
|
%
|
|
36.4
|
%
|
|
June 30,
2017 |
|
December 31,
2016 |
||||
Deferred tax assets:
|
|
|
|
||||
Net federal operating loss carryforwards
|
$
|
866.0
|
|
|
$
|
882.9
|
|
Net state operating loss carryforwards
|
11.6
|
|
|
12.3
|
|
||
Tax credits
|
.3
|
|
|
.7
|
|
||
Investments
|
14.0
|
|
|
17.8
|
|
||
Insurance liabilities
|
676.2
|
|
|
668.4
|
|
||
Other
|
58.2
|
|
|
65.6
|
|
||
Gross deferred tax assets
|
1,626.3
|
|
|
1,647.7
|
|
||
Deferred tax liabilities:
|
|
|
|
|
|
||
Present value of future profits and deferred acquisition costs
|
(276.5
|
)
|
|
(277.8
|
)
|
||
Accumulated other comprehensive income
|
(494.6
|
)
|
|
(344.1
|
)
|
||
Gross deferred tax liabilities
|
(771.1
|
)
|
|
(621.9
|
)
|
||
Net deferred tax assets before valuation allowance
|
855.2
|
|
|
1,025.8
|
|
||
Valuation allowance
|
(255.9
|
)
|
|
(240.2
|
)
|
||
Net deferred tax assets
|
599.3
|
|
|
785.6
|
|
||
Current income taxes prepaid (accrued)
|
(5.1
|
)
|
|
4.1
|
|
||
Income tax assets, net
|
$
|
594.2
|
|
|
$
|
789.7
|
|
|
|
Net operating loss
|
||
Year of expiration
|
|
carryforwards
|
||
2023
|
|
$
|
1,887.8
|
|
2025
|
|
85.2
|
|
|
2026
|
|
149.9
|
|
|
2027
|
|
10.8
|
|
|
2028
|
|
80.3
|
|
|
2029
|
|
213.2
|
|
|
2030
|
|
.3
|
|
|
2031
|
|
.2
|
|
|
2032
|
|
44.4
|
|
|
2033
|
|
.6
|
|
|
2034
|
|
.9
|
|
|
2035
|
|
.8
|
|
|
Total federal NOLs
|
|
$
|
2,474.4
|
|
|
June 30,
2017 |
|
December 31,
2016 |
||||
4.500% Senior Notes due May 2020
|
$
|
325.0
|
|
|
$
|
325.0
|
|
5.250% Senior Notes due May 2025
|
500.0
|
|
|
500.0
|
|
||
Revolving Credit Agreement (as defined below)
|
100.0
|
|
|
100.0
|
|
||
Unamortized debt issue costs
|
(11.1
|
)
|
|
(12.1
|
)
|
||
Direct corporate obligations
|
$
|
913.9
|
|
|
$
|
912.9
|
|
Year ending June 30,
|
|
||
2018
|
$
|
—
|
|
2019
|
100.0
|
|
|
2020
|
325.0
|
|
|
2021
|
—
|
|
|
2022
|
—
|
|
|
Thereafter
|
500.0
|
|
|
|
$
|
925.0
|
|
Amount
|
|
Maturity
|
|
Interest rate at
|
||
borrowed
|
|
date
|
|
June 30, 2017
|
||
$
|
50.0
|
|
|
January 2018
|
|
Variable rate – 1.508%
|
50.0
|
|
|
January 2018
|
|
Variable rate – 1.493%
|
|
50.0
|
|
|
February 2018
|
|
Variable rate – 1.489%
|
|
50.0
|
|
|
February 2018
|
|
Variable rate – 1.270%
|
|
50.0
|
|
|
July 2018
|
|
Variable rate – 1.642%
|
|
50.0
|
|
|
August 2018
|
|
Variable rate – 1.302%
|
|
50.0
|
|
|
January 2019
|
|
Variable rate – 1.578%
|
|
50.0
|
|
|
February 2019
|
|
Variable rate – 1.270%
|
|
100.0
|
|
|
March 2019
|
|
Variable rate – 1.689%
|
|
21.8
|
|
|
July 2019
|
|
Variable rate – 1.500%
|
|
15.0
|
|
|
October 2019
|
|
Variable rate – 1.683%
|
|
50.0
|
|
|
May 2020
|
|
Variable rate – 1.679%
|
|
21.8
|
|
|
June 2020
|
|
Fixed rate – 1.960%
|
|
25.0
|
|
|
September 2020
|
|
Variable rate – 1.921%
|
|
100.0
|
|
|
September 2020
|
|
Variable rate – 1.876%
|
|
50.0
|
|
|
September 2020
|
|
Variable rate – 1.882%
|
|
75.0
|
|
|
September 2020
|
|
Variable rate – 1.416%
|
|
100.0
|
|
|
October 2020
|
|
Variable rate – 1.260%
|
|
50.0
|
|
|
December 2020
|
|
Variable rate – 1.776%
|
|
100.0
|
|
|
July 2021
|
|
Variable rate – 1.708%
|
|
100.0
|
|
|
July 2021
|
|
Variable rate – 1.678%
|
|
28.2
|
|
|
August 2021
|
|
Fixed rate – 2.550%
|
|
57.7
|
|
|
August 2021
|
|
Variable rate - 1.701%
|
|
125.0
|
|
|
August 2021
|
|
Variable rate – 1.696%
|
|
50.0
|
|
|
September 2021
|
|
Variable rate – 1.738%
|
|
22.0
|
|
|
May 2022
|
|
Variable rate – 1.550%
|
|
100.0
|
|
|
May 2022
|
|
Variable rate – 1.656%
|
|
10.0
|
|
|
June 2022
|
|
Variable rate – 1.850%
|
|
25.0
|
|
|
March 2023
|
|
Fixed rate – 2.160%
|
|
20.5
|
|
|
June 2025
|
|
Fixed rate – 2.940%
|
|
$
|
1,647.0
|
|
|
|
|
|
Balance, December 31, 2016
|
173,754
|
|
|
Treasury stock purchased and retired
|
(5,429
|
)
|
|
Stock options exercised
|
511
|
|
|
Restricted and performance stock vested
|
183
|
|
(a)
|
Balance, June 30, 2017
|
169,019
|
|
|
(a)
|
Such amount was reduced by
101 thousand
shares which were tendered to the Company for the payment of required federal and state tax withholdings owed on the vesting of restricted and performance stock.
|
(i)
|
Require equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
|
(ii)
|
Simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value.
|
(iii)
|
Eliminate the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet.
|
(iv)
|
Require public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes.
|
(v)
|
Require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments.
|
(vi)
|
Require separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements.
|
(vii)
|
Clarify that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity's other deferred tax assets.
|
|
January 1, 2017
|
||||||||||||||
|
|
|
Effect of Adoption of Authoritative Guidance
|
|
|
||||||||||
|
Amounts prior to effect of adoption of authoritative guidance
|
|
Election to account for forfeitures as they occur
|
|
Recognition of excess tax benefits
|
|
As adjusted
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Income tax assets
|
$
|
1,029.9
|
|
|
$
|
.3
|
|
|
$
|
15.7
|
|
|
$
|
1,045.9
|
|
Valuation allowance for deferred income tax assets
|
(240.2
|
)
|
|
—
|
|
|
(15.7
|
)
|
|
(255.9
|
)
|
||||
Income tax assets, net
|
789.7
|
|
|
.3
|
|
|
—
|
|
|
790.0
|
|
||||
Total assets
|
31,975.2
|
|
|
.3
|
|
|
—
|
|
|
31,975.5
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Additional paid-in capital
|
3,212.1
|
|
|
.9
|
|
|
—
|
|
|
3,213.0
|
|
||||
Retained earnings
|
650.7
|
|
|
(.6
|
)
|
|
—
|
|
|
650.1
|
|
||||
Total shareholders' equity
|
4,486.9
|
|
|
.3
|
|
|
—
|
|
|
4,487.2
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Total liabilities and shareholders' equity
|
31,975.2
|
|
|
.3
|
|
|
—
|
|
|
31,975.5
|
|
|
Six months ended
|
||||||||||
|
June 30, 2016
|
||||||||||
|
Amounts prior to effect of adoption of authoritative guidance
|
|
Effect of adoption of authoritative guidance
|
|
As adjusted
|
||||||
Cash flows from operating activities:
|
|
|
|
|
|
||||||
Other operating costs
|
$
|
(381.4
|
)
|
|
$
|
3.2
|
|
|
$
|
(378.2
|
)
|
Net cash flow from operating activities
|
336.5
|
|
|
3.2
|
|
|
339.7
|
|
|||
|
|
|
|
|
|
||||||
Cash flows from financing activities:
|
|
|
|
|
|
||||||
Payments to repurchase common stock
|
(145.7
|
)
|
|
(3.2
|
)
|
|
(148.9
|
)
|
|||
Net cash used by financing activities
|
(104.5
|
)
|
|
(3.2
|
)
|
|
(107.7
|
)
|
|||
|
|
|
|
|
|
||||||
Net increase in cash and cash equivalents
|
4.9
|
|
|
—
|
|
|
4.9
|
|
|
Six months ended
|
||||||
|
June 30,
|
||||||
|
2017
|
|
2016
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
145.7
|
|
|
$
|
105.4
|
|
Adjustments to reconcile net income to net cash from operating activities:
|
|
|
|
|
|||
Amortization and depreciation
|
136.2
|
|
|
128.4
|
|
||
Income taxes
|
45.8
|
|
|
14.3
|
|
||
Insurance liabilities
|
222.8
|
|
|
213.7
|
|
||
Accrual and amortization of investment income
|
(134.8
|
)
|
|
(26.0
|
)
|
||
Deferral of policy acquisition costs
|
(126.6
|
)
|
|
(118.8
|
)
|
||
Net realized investment gains
|
(23.1
|
)
|
|
(11.7
|
)
|
||
Other
|
12.5
|
|
|
34.4
|
|
||
Net cash from operating activities
|
$
|
278.5
|
|
|
$
|
339.7
|
|
|
Six months ended
|
||||||
|
June 30,
|
||||||
|
2017
|
|
2016
|
||||
Stock options, restricted stock and performance units
|
$
|
12.1
|
|
|
$
|
14.7
|
|
|
June 30, 2017
|
||||||||||
|
VIEs
|
|
Eliminations
|
|
Net effect on
consolidated
balance sheet
|
||||||
Assets:
|
|
|
|
|
|
||||||
Investments held by variable interest entities
|
$
|
1,309.6
|
|
|
$
|
—
|
|
|
$
|
1,309.6
|
|
Notes receivable of VIEs held by insurance subsidiaries
|
—
|
|
|
(194.8
|
)
|
|
(194.8
|
)
|
|||
Cash and cash equivalents held by variable interest entities
|
391.1
|
|
|
—
|
|
|
391.1
|
|
|||
Accrued investment income
|
2.0
|
|
|
(.1
|
)
|
|
1.9
|
|
|||
Income tax assets, net
|
6.0
|
|
|
—
|
|
|
6.0
|
|
|||
Other assets
|
218.9
|
|
|
(1.6
|
)
|
|
217.3
|
|
|||
Total assets
|
$
|
1,927.6
|
|
|
$
|
(196.5
|
)
|
|
$
|
1,731.1
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|||
Other liabilities
|
$
|
213.1
|
|
|
$
|
(3.4
|
)
|
|
$
|
209.7
|
|
Borrowings related to variable interest entities
|
1,532.6
|
|
|
—
|
|
|
1,532.6
|
|
|||
Notes payable of VIEs held by insurance subsidiaries
|
193.8
|
|
|
(193.8
|
)
|
|
—
|
|
|||
Total liabilities
|
$
|
1,939.5
|
|
|
$
|
(197.2
|
)
|
|
$
|
1,742.3
|
|
|
December 31, 2016
|
||||||||||
|
VIEs
|
|
Eliminations
|
|
Net effect on
consolidated
balance sheet
|
||||||
Assets:
|
|
|
|
|
|
||||||
Investments held by variable interest entities
|
$
|
1,724.3
|
|
|
$
|
—
|
|
|
$
|
1,724.3
|
|
Notes receivable of VIEs held by insurance subsidiaries
|
—
|
|
|
(204.2
|
)
|
|
(204.2
|
)
|
|||
Cash and cash equivalents held by variable interest entities
|
189.3
|
|
|
—
|
|
|
189.3
|
|
|||
Accrued investment income
|
3.0
|
|
|
(.1
|
)
|
|
2.9
|
|
|||
Income tax assets, net
|
6.4
|
|
|
(1.3
|
)
|
|
5.1
|
|
|||
Other assets
|
13.1
|
|
|
(1.8
|
)
|
|
11.3
|
|
|||
Total assets
|
$
|
1,936.1
|
|
|
$
|
(207.4
|
)
|
|
$
|
1,728.7
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|||
Other liabilities
|
$
|
81.8
|
|
|
$
|
(6.4
|
)
|
|
$
|
75.4
|
|
Borrowings related to variable interest entities
|
1,662.8
|
|
|
—
|
|
|
1,662.8
|
|
|||
Notes payable of VIEs held by insurance subsidiaries
|
203.3
|
|
|
(203.3
|
)
|
|
—
|
|
|||
Total liabilities
|
$
|
1,947.9
|
|
|
$
|
(209.7
|
)
|
|
$
|
1,738.2
|
|
|
Amortized
cost
|
|
Estimated
fair
value
|
||||
|
(Dollars in millions)
|
||||||
Due in one year or less
|
$
|
6.7
|
|
|
$
|
6.7
|
|
Due after one year through five years
|
468.2
|
|
|
469.5
|
|
||
Due after five years through ten years
|
832.0
|
|
|
833.4
|
|
||
Total
|
$
|
1,306.9
|
|
|
$
|
1,309.6
|
|
•
|
Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities. Our Level 1 assets primarily include cash and cash equivalents and exchange traded securities.
|
•
|
Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data. Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies. These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace. Financial assets in this category primarily include: certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; certain mutual fund investments; most short-term investments; and non-exchange-traded derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.
|
•
|
Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions. Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information. Financial assets in this category include certain corporate securities (primarily certain below-investment grade privately placed securities), certain structured securities, mortgage loans, and other less liquid securities. Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) since their values include significant unobservable inputs including actuarial assumptions.
|
•
|
Investments held by VIEs
|
•
|
Other invested assets - derivatives
|
|
Quoted prices in active markets
for identical assets or liabilities (Level 1) |
|
Significant other observable inputs
(Level 2)
|
|
Significant unobservable inputs
(Level 3)
|
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
||||||||
Corporate securities
|
$
|
—
|
|
|
$
|
14,155.7
|
|
|
$
|
263.3
|
|
|
$
|
14,419.0
|
|
United States Treasury securities and obligations of United States government corporations and agencies
|
—
|
|
|
202.2
|
|
|
—
|
|
|
202.2
|
|
||||
States and political subdivisions
|
—
|
|
|
2,070.7
|
|
|
—
|
|
|
2,070.7
|
|
||||
Debt securities issued by foreign governments
|
—
|
|
|
53.0
|
|
|
3.9
|
|
|
56.9
|
|
||||
Asset-backed securities
|
—
|
|
|
2,783.8
|
|
|
59.6
|
|
|
2,843.4
|
|
||||
Collateralized debt obligations
|
—
|
|
|
224.9
|
|
|
2.5
|
|
|
227.4
|
|
||||
Commercial mortgage-backed securities
|
—
|
|
|
1,387.4
|
|
|
—
|
|
|
1,387.4
|
|
||||
Mortgage pass-through securities
|
—
|
|
|
2.3
|
|
|
—
|
|
|
2.3
|
|
||||
Collateralized mortgage obligations
|
—
|
|
|
861.9
|
|
|
.2
|
|
|
862.1
|
|
||||
Total fixed maturities, available for sale
|
—
|
|
|
21,741.9
|
|
|
329.5
|
|
|
22,071.4
|
|
||||
Equity securities - corporate securities
|
374.8
|
|
|
223.2
|
|
|
24.6
|
|
|
622.6
|
|
||||
Trading securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Corporate securities
|
—
|
|
|
20.8
|
|
|
—
|
|
|
20.8
|
|
||||
United States Treasury securities and obligations of United States government corporations and agencies
|
—
|
|
|
.5
|
|
|
—
|
|
|
.5
|
|
||||
Asset-backed securities
|
—
|
|
|
101.6
|
|
|
—
|
|
|
101.6
|
|
||||
Collateralized debt obligations
|
—
|
|
|
2.7
|
|
|
—
|
|
|
2.7
|
|
||||
Commercial mortgage-backed securities
|
—
|
|
|
103.6
|
|
|
—
|
|
|
103.6
|
|
||||
Collateralized mortgage obligations
|
—
|
|
|
74.9
|
|
|
—
|
|
|
74.9
|
|
||||
Equity securities
|
3.9
|
|
|
—
|
|
|
—
|
|
|
3.9
|
|
||||
Total trading securities
|
3.9
|
|
|
304.1
|
|
|
—
|
|
|
308.0
|
|
||||
Investments held by variable interest entities - corporate securities
|
—
|
|
|
1,309.6
|
|
|
—
|
|
|
1,309.6
|
|
||||
Other invested assets - derivatives
|
—
|
|
|
132.5
|
|
|
—
|
|
|
132.5
|
|
||||
Assets held in separate accounts
|
—
|
|
|
4.7
|
|
|
—
|
|
|
4.7
|
|
||||
Total assets carried at fair value by category
|
$
|
378.7
|
|
|
$
|
23,716.0
|
|
|
$
|
354.1
|
|
|
$
|
24,448.8
|
|
|
|
|
|
|
|
|
|
||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,205.4
|
|
|
$
|
1,205.4
|
|
|
Quoted prices in active markets
for identical assets or liabilities
(Level 1)
|
|
Significant other observable inputs
(Level 2)
|
|
Significant unobservable inputs
(Level 3)
|
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
||||||||
Corporate securities
|
$
|
—
|
|
|
$
|
13,252.4
|
|
|
$
|
258.5
|
|
|
$
|
13,510.9
|
|
United States Treasury securities and obligations of United States government corporations and agencies
|
—
|
|
|
164.3
|
|
|
—
|
|
|
164.3
|
|
||||
States and political subdivisions
|
—
|
|
|
1,988.9
|
|
|
—
|
|
|
1,988.9
|
|
||||
Debt securities issued by foreign governments
|
—
|
|
|
33.0
|
|
|
3.9
|
|
|
36.9
|
|
||||
Asset-backed securities
|
—
|
|
|
2,649.9
|
|
|
60.4
|
|
|
2,710.3
|
|
||||
Collateralized debt obligations
|
—
|
|
|
225.3
|
|
|
5.4
|
|
|
230.7
|
|
||||
Commercial mortgage-backed securities
|
—
|
|
|
1,504.2
|
|
|
32.0
|
|
|
1,536.2
|
|
||||
Mortgage pass-through securities
|
—
|
|
|
2.5
|
|
|
—
|
|
|
2.5
|
|
||||
Collateralized mortgage obligations
|
—
|
|
|
915.5
|
|
|
—
|
|
|
915.5
|
|
||||
Total fixed maturities, available for sale
|
—
|
|
|
20,736.0
|
|
|
360.2
|
|
|
21,096.2
|
|
||||
Equity securities - corporate securities
|
359.9
|
|
|
199.1
|
|
|
25.2
|
|
|
584.2
|
|
||||
Trading securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Corporate securities
|
—
|
|
|
19.0
|
|
|
—
|
|
|
19.0
|
|
||||
United States Treasury securities and obligations of United States government corporations and agencies
|
—
|
|
|
.5
|
|
|
—
|
|
|
.5
|
|
||||
Asset-backed securities
|
—
|
|
|
94.3
|
|
|
—
|
|
|
94.3
|
|
||||
Collateralized debt obligations
|
—
|
|
|
2.4
|
|
|
—
|
|
|
2.4
|
|
||||
Commercial mortgage-backed securities
|
—
|
|
|
163.9
|
|
|
—
|
|
|
163.9
|
|
||||
Collateralized mortgage obligations
|
—
|
|
|
78.4
|
|
|
—
|
|
|
78.4
|
|
||||
Equity securities
|
4.9
|
|
|
—
|
|
|
—
|
|
|
4.9
|
|
||||
Total trading securities
|
4.9
|
|
|
358.5
|
|
|
—
|
|
|
363.4
|
|
||||
Investments held by variable interest entities - corporate securities
|
—
|
|
|
1,724.3
|
|
|
—
|
|
|
1,724.3
|
|
||||
Other invested assets - derivatives
|
—
|
|
|
111.9
|
|
|
—
|
|
|
111.9
|
|
||||
Assets held in separate accounts
|
—
|
|
|
4.7
|
|
|
—
|
|
|
4.7
|
|
||||
Total assets carried at fair value by category
|
$
|
364.8
|
|
|
$
|
23,134.5
|
|
|
$
|
385.4
|
|
|
$
|
23,884.7
|
|
|
|
|
|
|
|
|
|
||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,092.3
|
|
|
$
|
1,092.3
|
|
|
December 31, 2016
|
||||||||||||||||||
|
Quoted prices in active markets for identical assets or liabilities
(Level 1)
|
|
Significant other observable inputs
(Level 2)
|
|
Significant unobservable inputs
(Level 3)
|
|
Total estimated fair value
|
|
Total carrying amount
|
||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
Mortgage loans
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,800.1
|
|
|
$
|
1,800.1
|
|
|
$
|
1,768.0
|
|
Policy loans
|
—
|
|
|
—
|
|
|
112.0
|
|
|
112.0
|
|
|
112.0
|
|
|||||
Other invested assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
Company-owned life insurance
|
—
|
|
|
165.0
|
|
|
—
|
|
|
165.0
|
|
|
165.0
|
|
|||||
Cash and cash equivalents:
|
|
|
|
|
|
|
|
|
|
||||||||||
Unrestricted
|
473.6
|
|
|
5.3
|
|
|
—
|
|
|
478.9
|
|
|
478.9
|
|
|||||
Held by variable interest entities
|
189.3
|
|
|
—
|
|
|
—
|
|
|
189.3
|
|
|
189.3
|
|
|||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Policyholder account balances
|
—
|
|
|
—
|
|
|
10,912.7
|
|
|
10,912.7
|
|
|
10,912.7
|
|
|||||
Investment borrowings
|
—
|
|
|
1,650.0
|
|
|
—
|
|
|
1,650.0
|
|
|
1,647.4
|
|
|||||
Borrowings related to variable interest entities
|
—
|
|
|
1,675.2
|
|
|
—
|
|
|
1,675.2
|
|
|
1,662.8
|
|
|||||
Notes payable – direct corporate obligations
|
—
|
|
|
931.9
|
|
|
—
|
|
|
931.9
|
|
|
912.9
|
|
|
|
June 30, 2017
|
|
|
||||||||||||||||||||||||||||
|
|
Beginning balance as of March 31, 2017
|
|
Purchases, sales, issuances and settlements, net (b)
|
|
Total realized and unrealized gains (losses) included in net income
|
|
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)
|
|
Transfers into Level 3 (a)
|
|
Transfers out of Level 3 (a)
|
|
Ending balance as of June 30, 2017
|
|
Amount of total gains (losses) for the three months ended June 30, 2017 included in our net income relating to assets and liabilities still held as of the reporting date
|
||||||||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Corporate securities
|
|
$
|
288.8
|
|
|
$
|
(18.3
|
)
|
|
$
|
7.2
|
|
|
$
|
(8.9
|
)
|
|
$
|
11.6
|
|
|
$
|
(17.1
|
)
|
|
$
|
263.3
|
|
|
$
|
(3.4
|
)
|
Debt securities issued by foreign governments
|
|
3.9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3.9
|
|
|
—
|
|
||||||||
Asset-backed securities
|
|
67.2
|
|
|
(4.2
|
)
|
|
—
|
|
|
.6
|
|
|
—
|
|
|
(4.0
|
)
|
|
59.6
|
|
|
—
|
|
||||||||
Collateralized debt obligations
|
|
11.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9.0
|
)
|
|
2.5
|
|
|
—
|
|
||||||||
Commercial mortgage-backed securities
|
|
14.9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14.9
|
)
|
|
—
|
|
|
—
|
|
||||||||
Collateralized mortgage obligations
|
|
—
|
|
|
(7.3
|
)
|
|
—
|
|
|
(1.4
|
)
|
|
8.9
|
|
|
—
|
|
|
.2
|
|
|
—
|
|
||||||||
Total fixed maturities, available for sale
|
|
386.3
|
|
|
(29.8
|
)
|
|
7.2
|
|
|
(9.7
|
)
|
|
20.5
|
|
|
(45.0
|
)
|
|
329.5
|
|
|
(3.4
|
)
|
||||||||
Equity securities - corporate securities
|
|
24.3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
.3
|
|
|
—
|
|
|
24.6
|
|
|
—
|
|
||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
|
(1,159.2
|
)
|
|
(48.7
|
)
|
|
2.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,205.4
|
)
|
|
2.5
|
|
(a)
|
Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.
|
(b)
|
Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts. The following summarizes such activity for the three months ended
June 30, 2017
(dollars in millions):
|
|
Purchases
|
|
Sales
|
|
Issuances
|
|
Settlements
|
|
Purchases, sales, issuances and settlements, net
|
||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
Corporate securities
|
$
|
10.9
|
|
|
$
|
(29.2
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(18.3
|
)
|
Asset-backed securities
|
—
|
|
|
(4.2
|
)
|
|
—
|
|
|
—
|
|
|
(4.2
|
)
|
|||||
Collateralized mortgage obligations
|
—
|
|
|
(7.3
|
)
|
|
—
|
|
|
—
|
|
|
(7.3
|
)
|
|||||
Total fixed maturities, available for sale
|
10.9
|
|
|
(40.7
|
)
|
|
—
|
|
|
—
|
|
|
(29.8
|
)
|
|||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
(45.8
|
)
|
|
2.2
|
|
|
(21.2
|
)
|
|
16.1
|
|
|
(48.7
|
)
|
|
|
June 30, 2017
|
|
|
||||||||||||||||||||||||||||
|
|
Beginning balance as of December 31, 2016
|
|
Purchases, sales, issuances and settlements, net (b)
|
|
Total realized and unrealized gains (losses) included in net income
|
|
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)
|
|
Transfers into Level 3 (a)
|
|
Transfers out of Level 3 (a)
|
|
Ending balance as of June 30, 2017
|
|
Amount of total gains (losses) for the six months ended June 30, 2017 included in our net income relating to assets and liabilities still held as of the reporting date
|
||||||||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Corporate securities
|
|
$
|
258.5
|
|
|
$
|
(14.1
|
)
|
|
$
|
7.8
|
|
|
$
|
(.5
|
)
|
|
$
|
11.6
|
|
|
$
|
—
|
|
|
$
|
263.3
|
|
|
$
|
(6.7
|
)
|
Debt securities issued by foreign governments
|
|
3.9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3.9
|
|
|
—
|
|
||||||||
Asset-backed securities
|
|
60.4
|
|
|
5.8
|
|
|
—
|
|
|
1.1
|
|
|
—
|
|
|
(7.7
|
)
|
|
59.6
|
|
|
—
|
|
||||||||
Collateralized debt obligations
|
|
5.4
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2.9
|
)
|
|
2.5
|
|
|
—
|
|
||||||||
Commercial mortgage-backed securities
|
|
32.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(32.0
|
)
|
|
—
|
|
|
—
|
|
||||||||
Collateralized mortgage obligations
|
|
—
|
|
|
(7.9
|
)
|
|
—
|
|
|
(1.4
|
)
|
|
9.5
|
|
|
—
|
|
|
.2
|
|
|
—
|
|
||||||||
Total fixed maturities, available for sale
|
|
360.2
|
|
|
(16.2
|
)
|
|
7.8
|
|
|
(.8
|
)
|
|
21.1
|
|
|
(42.6
|
)
|
|
329.5
|
|
|
(6.7
|
)
|
||||||||
Equity securities - corporate securities
|
|
25.2
|
|
|
(.1
|
)
|
|
(.1
|
)
|
|
(.4
|
)
|
|
—
|
|
|
—
|
|
|
24.6
|
|
|
—
|
|
||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
|
(1,092.3
|
)
|
|
(117.9
|
)
|
|
4.8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,205.4
|
)
|
|
4.8
|
|
(a)
|
Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.
|
(b)
|
Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts. The following summarizes such activity for the six months ended
June 30, 2017
(dollars in millions):
|
|
Purchases
|
|
Sales
|
|
Issuances
|
|
Settlements
|
|
Purchases, sales, issuances and settlements, net
|
||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
Corporate securities
|
$
|
34.2
|
|
|
$
|
(48.3
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(14.1
|
)
|
Asset-backed securities
|
12.0
|
|
|
(6.2
|
)
|
|
—
|
|
|
—
|
|
|
5.8
|
|
|||||
Collateralized mortgage obligations
|
—
|
|
|
(7.9
|
)
|
|
—
|
|
|
—
|
|
|
(7.9
|
)
|
|||||
Total fixed maturities, available for sale
|
46.2
|
|
|
(62.4
|
)
|
|
—
|
|
|
—
|
|
|
(16.2
|
)
|
|||||
Equity securities - corporate securities
|
—
|
|
|
(.1
|
)
|
|
—
|
|
|
—
|
|
|
(.1
|
)
|
|||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
(89.1
|
)
|
|
3.5
|
|
|
(64.3
|
)
|
|
32.0
|
|
|
(117.9
|
)
|
|
June 30, 2016
|
|
|
||||||||||||||||||||||||||||
|
Beginning balance as of March 31, 2016
|
|
Purchases, sales, issuances and settlements, net (b)
|
|
Total realized and unrealized gains (losses) included in net income
|
|
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)
|
|
Transfers into Level 3 (a)
|
|
Transfers out of Level 3 (a)
|
|
Ending balance as of June 30, 2016
|
|
Amount of total gains (losses) for the three months ended June 30, 2016 included in our net income relating to assets and liabilities still held as of the reporting date
|
||||||||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Corporate securities
|
$
|
173.3
|
|
|
$
|
(2.6
|
)
|
|
$
|
—
|
|
|
$
|
4.7
|
|
|
$
|
—
|
|
|
$
|
(0.8
|
)
|
|
$
|
174.6
|
|
|
$
|
—
|
|
Debt securities issued by foreign governments
|
—
|
|
|
4.0
|
|
|
—
|
|
|
.1
|
|
|
—
|
|
|
—
|
|
|
4.1
|
|
|
—
|
|
||||||||
Asset-backed securities
|
43.8
|
|
|
4.7
|
|
|
—
|
|
|
1.6
|
|
|
—
|
|
|
(11.0
|
)
|
|
39.1
|
|
|
—
|
|
||||||||
Commercial mortgage-backed securities
|
1.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.1
|
|
|
—
|
|
||||||||
Total fixed maturities, available for sale
|
218.2
|
|
|
6.1
|
|
|
—
|
|
|
6.4
|
|
|
—
|
|
|
(11.8
|
)
|
|
218.9
|
|
|
—
|
|
||||||||
Equity securities - corporate securities
|
32.4
|
|
|
1.1
|
|
|
(12.8
|
)
|
|
.7
|
|
|
—
|
|
|
—
|
|
|
21.4
|
|
|
(12.8
|
)
|
||||||||
Trading securities - commercial mortgage-backed securities
|
39.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(39.0
|
)
|
|
—
|
|
|
—
|
|
||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
(1,096.0
|
)
|
|
(14.3
|
)
|
|
(16.7
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,127.0
|
)
|
|
(16.7
|
)
|
(a)
|
Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.
|
(b)
|
Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts. The following summarizes such activity for the three months ended
June 30, 2016
(dollars in millions):
|
|
Purchases
|
|
Sales
|
|
Issuances
|
|
Settlements
|
|
Purchases, sales, issuances and settlements, net
|
||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
Corporate securities
|
$
|
—
|
|
|
$
|
(2.6
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(2.6
|
)
|
Debt securities issued by foreign governments
|
4.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4.0
|
|
|||||
Asset-backed securities
|
4.8
|
|
|
(.1
|
)
|
|
—
|
|
|
—
|
|
|
4.7
|
|
|||||
Total fixed maturities, available for sale
|
8.8
|
|
|
(2.7
|
)
|
|
—
|
|
|
—
|
|
|
6.1
|
|
|||||
Equity securities - corporate securities
|
1.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.1
|
|
|||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
(29.4
|
)
|
|
1.9
|
|
|
(2.7
|
)
|
|
15.9
|
|
|
(14.3
|
)
|
|
June 30, 2016
|
|
|
||||||||||||||||||||||||||||
|
Beginning balance as of December 31, 2015
|
|
Purchases, sales, issuances and settlements, net (b)
|
|
Total realized and unrealized gains (losses) included in net income
|
|
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)
|
|
Transfers into Level 3 (a)
|
|
Transfers out of Level 3 (a)
|
|
Ending balance as of June 30, 2016
|
|
Amount of total gains (losses) for the six months ended June 30, 2016 included in our net income relating to assets and liabilities still held as of the reporting date
|
||||||||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Corporate securities
|
$
|
170.4
|
|
|
$
|
(14.4
|
)
|
|
$
|
(7.0
|
)
|
|
$
|
12.3
|
|
|
$
|
20.3
|
|
|
$
|
(7.0
|
)
|
|
$
|
174.6
|
|
|
$
|
(5.6
|
)
|
Debt securities issued by foreign governments
|
—
|
|
|
4.0
|
|
|
—
|
|
|
.1
|
|
|
—
|
|
|
—
|
|
|
4.1
|
|
|
—
|
|
||||||||
Asset-backed securities
|
35.9
|
|
|
14.5
|
|
|
—
|
|
|
2.4
|
|
|
—
|
|
|
(13.7
|
)
|
|
39.1
|
|
|
—
|
|
||||||||
Commercial mortgage-backed securities
|
1.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.1
|
|
|
—
|
|
||||||||
Mortgage pass-through securities
|
.1
|
|
|
(.1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Total fixed maturities, available for sale
|
207.5
|
|
|
4.0
|
|
|
(7.0
|
)
|
|
14.8
|
|
|
20.3
|
|
|
(20.7
|
)
|
|
218.9
|
|
|
(5.6
|
)
|
||||||||
Equity securities - corporate securities
|
32.0
|
|
|
2.2
|
|
|
(12.8
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
21.4
|
|
|
(12.8
|
)
|
||||||||
Trading securities - commercial mortgage-backed securities
|
39.9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(39.9
|
)
|
|
—
|
|
|
—
|
|
||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
(1,057.1
|
)
|
|
(18.3
|
)
|
|
(51.6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,127.0
|
)
|
|
(51.6
|
)
|
(a)
|
Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.
|
(b)
|
Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts. The following summarizes such activity for the six months ended
June 30, 2016
(dollars in millions):
|
|
Purchases
|
|
Sales
|
|
Issuances
|
|
Settlements
|
|
Purchases, sales, issuances and settlements, net
|
||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
Corporate securities
|
$
|
—
|
|
|
$
|
(14.4
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(14.4
|
)
|
Debt securities issued by foreign governments
|
4.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4.0
|
|
|||||
Asset-backed securities
|
14.8
|
|
|
(.3
|
)
|
|
—
|
|
|
—
|
|
|
14.5
|
|
|||||
Mortgage pass-through securities
|
—
|
|
|
(.1
|
)
|
|
—
|
|
|
—
|
|
|
(.1
|
)
|
|||||
Total fixed maturities, available for sale
|
18.8
|
|
|
(14.8
|
)
|
|
—
|
|
|
—
|
|
|
4.0
|
|
|||||
Equity securities - corporate securities
|
2.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.2
|
|
|||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Future policy benefits - embedded derivatives associated with fixed index annuity products
|
(63.4
|
)
|
|
16.1
|
|
|
(2.9
|
)
|
|
31.9
|
|
|
(18.3
|
)
|
|
Fair value at June 30, 2017
|
|
Valuation techniques
|
|
Unobservable inputs
|
|
Range (weighted average)
|
||
Assets:
|
|
|
|
|
|
|
|
||
Corporate securities (a)
|
$
|
152.0
|
|
|
Discounted cash flow analysis
|
|
Discount margins
|
|
1.60% - 40.56% (13.44%)
|
Corporate securities (b)
|
8.4
|
|
|
Recovery method
|
|
Percent of recovery expected
|
|
0% - 100% (46.44%)
|
|
Asset-backed securities (c)
|
24.8
|
|
|
Discounted cash flow analysis
|
|
Discount margins
|
|
1.88% - 3.43% (2.59%)
|
|
Equity security (d)
|
21.6
|
|
|
Market multiple
|
|
Projected cash flows
|
|
0.4% - 6.2% (5.9%)
|
|
Equity security (b)
|
3.0
|
|
|
Recovery method
|
|
Percent of recovery expected
|
|
0% - 100% (78.78%)
|
|
Other assets categorized as Level 3 (e)
|
144.3
|
|
|
Unadjusted third-party price source
|
|
Not applicable
|
|
Not applicable
|
|
Total
|
354.1
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
||
Future policy benefits (f)
|
1,205.4
|
|
|
Discounted projected embedded derivatives
|
|
Projected portfolio yields
|
|
5.15% - 5.61% (5.59%)
|
|
|
|
|
|
|
Discount rates
|
|
0.41% - 2.76% (1.91%)
|
||
|
|
|
|
|
Surrender rates
|
|
0.94% - 46.48% (13.52%)
|
(a)
|
Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.
|
(b)
|
Corporate and equity securities - The significant unobservable input used in the fair value measurement of these corporate and equity securities is percentage of recovery expected. Significant increases (decreases) in percentage of recovery expected in isolation would result in a significantly higher (lower) fair value measurement.
|
(c)
|
Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.
|
(d)
|
Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is projected cash flows. Generally, increases (decreases) in the projected cash flows would result in higher (lower) fair value measurements.
|
(e)
|
Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.
|
(f)
|
Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.
|
|
Fair value at December 31, 2016
|
|
Valuation techniques
|
|
Unobservable inputs
|
|
Range (weighted average)
|
||
Assets:
|
|
|
|
|
|
|
|
||
Corporate securities (a)
|
$
|
148.5
|
|
|
Discounted cash flow analysis
|
|
Discount margins
|
|
1.35% - 27.71% (13.52%)
|
Corporate securities (b)
|
14.8
|
|
|
Recovery method
|
|
Percent of recovery expected
|
|
5% - 69% (55%)
|
|
Asset-backed securities (c)
|
24.0
|
|
|
Discounted cash flow analysis
|
|
Discount margins
|
|
2.06% - 3.64% (2.76%)
|
|
Equity security (d)
|
25.2
|
|
|
Market multiple
|
|
Projected cash flows
|
|
0.4% - 6.2% (5.9%)
|
|
Other assets categorized as Level 3 (e)
|
172.9
|
|
|
Unadjusted third-party price source
|
|
Not applicable
|
|
Not applicable
|
|
Total
|
385.4
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
||
Future policy benefits (f)
|
1,092.3
|
|
|
Discounted projected embedded derivatives
|
|
Projected portfolio yields
|
|
5.15% - 5.61% (5.59%)
|
|
|
|
|
|
|
Discount rates
|
|
0.18% - 3.06% (2.07%)
|
||
|
|
|
|
|
Surrender rates
|
|
0.94% - 46.48% (13.52%)
|
(a)
|
Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.
|
(b)
|
Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is percentage of recovery expected. Significant increases (decreases) in percentage of recovery expected in isolation would result in a significantly higher (lower) fair value measurement.
|
(c)
|
Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.
|
(d)
|
Equity security - The significant unobservable input used in the fair value measurement of these equity securities is projected cash flows. Generally, increases (decreases) in the projected cash flows would result in higher (lower) fair value measurements.
|
(e)
|
Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.
|
(f)
|
Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.
|
ITEM 2.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
•
|
changes in or sustained low interest rates causing reductions in investment income, the margins of our fixed annuity and life insurance businesses, and sales of, and demand for, our products;
|
•
|
expectations of lower future investment earnings may cause us to accelerate amortization, write down the balance of insurance acquisition costs or establish additional liabilities for insurance products;
|
•
|
general economic, market and political conditions and uncertainties, including the performance and fluctuations of the financial markets which may affect the value of our investments as well as our ability to raise capital or refinance existing indebtedness and the cost of doing so;
|
•
|
the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject;
|
•
|
our ability to make anticipated changes to certain non-guaranteed elements of our life insurance products;
|
•
|
our ability to obtain adequate and timely rate increases on our health products, including our long-term care business;
|
•
|
the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries;
|
•
|
mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates and other factors which may affect the profitability of our insurance products;
|
•
|
changes in our assumptions related to deferred acquisition costs or the present value of future profits;
|
•
|
the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on their value;
|
•
|
our assumption that the positions we take on our tax return filings will not be successfully challenged by the IRS;
|
•
|
changes in accounting principles and the interpretation thereof;
|
•
|
our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements;
|
•
|
our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems;
|
•
|
performance and valuation of our investments, including the impact of realized losses (including other-than-temporary impairment charges);
|
•
|
our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition;
|
•
|
our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs;
|
•
|
our ability to maintain effective controls over financial reporting;
|
•
|
our ability to continue to recruit and retain productive agents and distribution partners;
|
•
|
customer response to new products, distribution channels and marketing initiatives;
|
•
|
our ability to achieve additional upgrades of the financial strength ratings of CNO and our insurance company subsidiaries as well as the impact of our ratings on our business, our ability to access capital, and the cost of capital;
|
•
|
regulatory changes or actions, including those relating to regulation of the financial affairs of our insurance companies, such as the payment of dividends and surplus debenture interest to us, regulation of the sale, underwriting and pricing of products, and health care regulation affecting health insurance products;
|
•
|
changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products or affect the value of our deferred tax assets;
|
•
|
availability and effectiveness of reinsurance arrangements, as well as the impact of any defaults or failure of reinsurers to perform;
|
•
|
the amount we may need to pay to a reinsurer and the earnings charge we may incur in connection with a long-term care reinsurance transaction;
|
•
|
the performance of third party service providers and potential difficulties arising from outsourcing arrangements;
|
•
|
the growth rate of sales, collected premiums, annuity deposits and assets;
|
•
|
interruption in telecommunication, information technology or other operational systems or failure to maintain the security, confidentiality or privacy of sensitive data on such systems;
|
•
|
events of terrorism, cyber attacks, natural disasters or other catastrophic events, including losses from a disease pandemic;
|
•
|
ineffectiveness of risk management policies and procedures in identifying, monitoring and managing risks; and
|
•
|
the risk factors or uncertainties listed from time to time in our filings with the SEC.
|
•
|
Bankers Life,
which markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents, financial and investment advisors, and sales managers supported by a network of community-based sales offices. The Bankers Life segment includes primarily the business of Bankers Life. Bankers Life also has various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute Medicare Advantage and prescription drug plans products in exchange for a fee.
|
•
|
Washington National,
which markets and distributes supplemental health (including specified disease, accident and hospital indemnity insurance products) and life insurance to middle-income consumers at home and at the worksite. These products are marketed through Performance Matters Associates, Inc. ("PMA") and through independent marketing organizations and insurance agencies including worksite marketing. The products being marketed are underwritten by Washington National. This segment's business also includes certain closed blocks of annuities and Medicare supplement policies which are no longer being actively marketed by this segment and were primarily issued or acquired by Washington National.
|
•
|
Colonial Penn
, which markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, the internet and telemarketing. The Colonial Penn segment includes primarily the business of Colonial Penn.
|
•
|
Long-term care in run-off
consists of the long-term care business that was recaptured due to the termination of certain reinsurance agreements effective September 30, 2016. This business is not actively marketed and was issued or acquired by Washington National and BCLIC.
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Adjusted EBIT (a non-GAAP measure) (a):
|
|
|
|
|
|
|
|
||||||||
Bankers Life
|
$
|
112.6
|
|
|
$
|
93.3
|
|
|
$
|
202.3
|
|
|
$
|
170.9
|
|
Washington National
|
23.6
|
|
|
21.5
|
|
|
47.1
|
|
|
47.8
|
|
||||
Colonial Penn
|
8.0
|
|
|
3.0
|
|
|
7.7
|
|
|
(3.8
|
)
|
||||
Long-term care in run-off
|
1.7
|
|
|
—
|
|
|
2.1
|
|
|
—
|
|
||||
Adjusted EBIT from business segments
|
145.9
|
|
|
117.8
|
|
|
259.2
|
|
|
214.9
|
|
||||
Corporate operations, excluding corporate interest expense
|
(13.2
|
)
|
|
(7.0
|
)
|
|
(22.1
|
)
|
|
(15.1
|
)
|
||||
Adjusted EBIT
|
132.7
|
|
|
110.8
|
|
|
237.1
|
|
|
199.8
|
|
||||
Corporate interest expense
|
(11.6
|
)
|
|
(11.4
|
)
|
|
(23.1
|
)
|
|
(22.8
|
)
|
||||
Operating earnings before taxes
|
121.1
|
|
|
99.4
|
|
|
214.0
|
|
|
177.0
|
|
||||
Tax expense on operating income
|
42.5
|
|
|
35.7
|
|
|
75.6
|
|
|
63.7
|
|
||||
Net operating income (a)
|
78.6
|
|
|
63.7
|
|
|
138.4
|
|
|
113.3
|
|
||||
Net realized investment gains (losses) (net of related amortization)
|
14.9
|
|
|
12.0
|
|
|
22.8
|
|
|
11.0
|
|
||||
Fair value changes in embedded derivative liabilities (net of related amortization)
|
(5.9
|
)
|
|
(16.5
|
)
|
|
(10.3
|
)
|
|
(46.0
|
)
|
||||
Fair value changes related to agent deferred compensation plan
|
—
|
|
|
(12.3
|
)
|
|
—
|
|
|
(18.3
|
)
|
||||
Other
|
(1.6
|
)
|
|
.1
|
|
|
(1.3
|
)
|
|
(.5
|
)
|
||||
Non-operating income (loss) before taxes
|
7.4
|
|
|
(16.7
|
)
|
|
11.2
|
|
|
(53.8
|
)
|
||||
Income tax expense (benefit):
|
|
|
|
|
|
|
|
||||||||
On non-operating income (loss)
|
2.6
|
|
|
(5.9
|
)
|
|
3.9
|
|
|
(18.9
|
)
|
||||
Valuation allowance for deferred tax assets
|
—
|
|
|
(7.0
|
)
|
|
—
|
|
|
(27.0
|
)
|
||||
Net non-operating income (loss)
|
4.8
|
|
|
(3.8
|
)
|
|
7.3
|
|
|
(7.9
|
)
|
||||
Net income
|
$
|
83.4
|
|
|
$
|
59.9
|
|
|
$
|
145.7
|
|
|
$
|
105.4
|
|
Per diluted share:
|
|
|
|
|
|
|
|
||||||||
Net operating income
|
$
|
.45
|
|
|
$
|
.35
|
|
|
$
|
.80
|
|
|
$
|
.63
|
|
Net realized investment gains (losses) (net of related amortization and taxes)
|
.06
|
|
|
.04
|
|
|
.09
|
|
|
.04
|
|
||||
Fair value changes in embedded derivative liabilities (net of related amortization and taxes)
|
(.02
|
)
|
|
(.06
|
)
|
|
(.04
|
)
|
|
(.17
|
)
|
||||
Fair value changes related to agent deferred compensation plan (net of taxes)
|
—
|
|
|
(.04
|
)
|
|
—
|
|
|
(.07
|
)
|
||||
Valuation allowance for deferred tax assets
|
—
|
|
|
.04
|
|
|
—
|
|
|
.15
|
|
||||
Other
|
(.01
|
)
|
|
—
|
|
|
(.01
|
)
|
|
—
|
|
||||
Net income
|
$
|
.48
|
|
|
$
|
.33
|
|
|
$
|
.84
|
|
|
$
|
.58
|
|
(a)
|
Management believes that an analysis of net operating income provides a clearer comparison of the operating results of the Company from period to period because it excludes: (i) net realized investment gains or losses, net of related amortization; (ii) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, net of related amortization; (iii) fair value changes related to the agent deferred compensation plan; and (iv)
other non-operating items consisting primarily of earnings attributable to variable interest entities
. Net realized investment gains or losses include: (i) gains or losses on the sales of investments; (ii) other-than-temporary impairments recognized through net income; and (iii) changes in fair value of certain fixed maturity investments with embedded derivatives. Adjusted EBIT is presented as net operating income excluding corporate interest expense and income tax expense. The table above reconciles the non-GAAP measures to the corresponding GAAP measure.
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Pre-tax operating earnings (a non-GAAP measure) (a):
|
|
|
|
|
|
|
|
||||||||
Bankers Life
|
$
|
112.6
|
|
|
$
|
93.3
|
|
|
$
|
202.3
|
|
|
$
|
170.9
|
|
Washington National
|
23.6
|
|
|
21.5
|
|
|
47.1
|
|
|
47.8
|
|
||||
Colonial Penn
|
8.0
|
|
|
3.0
|
|
|
7.7
|
|
|
(3.8
|
)
|
||||
Long-term care in run-off
|
1.7
|
|
|
—
|
|
|
2.1
|
|
|
—
|
|
||||
Corporate operations
|
(24.8
|
)
|
|
(18.4
|
)
|
|
(45.2
|
)
|
|
(37.9
|
)
|
||||
|
121.1
|
|
|
99.4
|
|
|
214.0
|
|
|
177.0
|
|
||||
Net realized investment gains (losses), net of related amortization:
|
|
|
|
|
|
|
|
||||||||
Bankers Life
|
13.5
|
|
|
4.5
|
|
|
15.2
|
|
|
(2.0
|
)
|
||||
Washington National
|
4.1
|
|
|
13.8
|
|
|
6.1
|
|
|
26.8
|
|
||||
Colonial Penn
|
(.1
|
)
|
|
.7
|
|
|
(.2
|
)
|
|
(.5
|
)
|
||||
Long-term care in run-off
|
1.4
|
|
|
—
|
|
|
1.1
|
|
|
—
|
|
||||
Corporate operations
|
(4.0
|
)
|
|
(7.0
|
)
|
|
.6
|
|
|
(13.3
|
)
|
||||
|
14.9
|
|
|
12.0
|
|
|
22.8
|
|
|
11.0
|
|
||||
Fair value changes in embedded derivative liabilities, net of related amortization:
|
|
|
|
|
|
|
|
||||||||
Bankers Life
|
(5.9
|
)
|
|
(16.4
|
)
|
|
(10.3
|
)
|
|
(45.5
|
)
|
||||
Washington National
|
—
|
|
|
(.1
|
)
|
|
—
|
|
|
(.5
|
)
|
||||
|
(5.9
|
)
|
|
(16.5
|
)
|
|
(10.3
|
)
|
|
(46.0
|
)
|
||||
Earnings attributable to VIEs:
|
|
|
|
|
|
|
|
||||||||
Corporate operations
|
(1.6
|
)
|
|
.1
|
|
|
(1.3
|
)
|
|
(.5
|
)
|
||||
Fair value changes related to agent deferred compensation plan:
|
|
|
|
|
|
|
|
||||||||
Corporate operations
|
—
|
|
|
(12.3
|
)
|
|
—
|
|
|
(18.3
|
)
|
||||
Income (loss) before income taxes:
|
|
|
|
|
|
|
|
||||||||
Bankers Life
|
120.2
|
|
|
81.4
|
|
|
207.2
|
|
|
123.4
|
|
||||
Washington National
|
27.7
|
|
|
35.2
|
|
|
53.2
|
|
|
74.1
|
|
||||
Colonial Penn
|
7.9
|
|
|
3.7
|
|
|
7.5
|
|
|
(4.3
|
)
|
||||
Long-term care in run-off
|
3.1
|
|
|
—
|
|
|
3.2
|
|
|
—
|
|
||||
Corporate operations
|
(30.4
|
)
|
|
(37.6
|
)
|
|
(45.9
|
)
|
|
(70.0
|
)
|
||||
Income before income taxes
|
$
|
128.5
|
|
|
$
|
82.7
|
|
|
$
|
225.2
|
|
|
$
|
123.2
|
|
(a)
|
These non-GAAP measures as presented in the above table and in the following segment financial data and discussions of segment results exclude net realized investment gains (losses), fair value changes in embedded derivative liabilities, net of related amortization, fair value changes related to the agent deferred compensation plan and earnings attributable to VIEs and before income taxes. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Premium collections:
|
|
|
|
|
|
|
|
||||||||
Annuities
|
$
|
264.3
|
|
|
$
|
206.4
|
|
|
$
|
521.8
|
|
|
$
|
440.0
|
|
Medicare supplement and other supplemental health
|
298.9
|
|
|
303.9
|
|
|
614.9
|
|
|
617.0
|
|
||||
Life
|
117.4
|
|
|
117.9
|
|
|
231.7
|
|
|
231.9
|
|
||||
Total collections
|
$
|
680.6
|
|
|
$
|
628.2
|
|
|
$
|
1,368.4
|
|
|
$
|
1,288.9
|
|
Average liabilities for insurance products:
|
|
|
|
|
|
|
|
||||||||
Fixed index annuities
|
$
|
5,050.7
|
|
|
$
|
4,461.1
|
|
|
$
|
4,961.1
|
|
|
$
|
4,394.3
|
|
Fixed interest annuities
|
2,934.9
|
|
|
3,221.1
|
|
|
2,973.6
|
|
|
3,259.3
|
|
||||
SPIAs and supplemental contracts:
|
|
|
|
|
|
|
|
||||||||
Mortality based
|
162.2
|
|
|
177.1
|
|
|
163.5
|
|
|
179.2
|
|
||||
Deposit based
|
149.8
|
|
|
153.8
|
|
|
150.7
|
|
|
154.6
|
|
||||
Health:
|
|
|
|
|
|
|
|
||||||||
Long-term care
|
4,946.6
|
|
|
4,980.8
|
|
|
4,906.3
|
|
|
4,897.5
|
|
||||
Medicare supplement
|
337.0
|
|
|
335.4
|
|
|
340.2
|
|
|
337.4
|
|
||||
Other health
|
55.4
|
|
|
49.7
|
|
|
54.8
|
|
|
49.2
|
|
||||
Life:
|
|
|
|
|
|
|
|
||||||||
Interest sensitive
|
772.1
|
|
|
706.6
|
|
|
764.7
|
|
|
697.9
|
|
||||
Non-interest sensitive
|
1,081.0
|
|
|
1,009.6
|
|
|
1,071.6
|
|
|
999.6
|
|
||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$
|
15,489.7
|
|
|
$
|
15,095.2
|
|
|
$
|
15,386.5
|
|
|
$
|
14,969.0
|
|
Revenues:
|
|
|
|
|
|
|
|
||||||||
Insurance policy income
|
$
|
419.1
|
|
|
$
|
419.6
|
|
|
$
|
838.2
|
|
|
$
|
832.8
|
|
Net investment income:
|
|
|
|
|
|
|
|
||||||||
General account invested assets
|
237.7
|
|
|
225.1
|
|
|
468.8
|
|
|
447.1
|
|
||||
Fixed index products
|
19.2
|
|
|
2.8
|
|
|
61.0
|
|
|
(5.0
|
)
|
||||
Fee revenue and other income
|
10.6
|
|
|
7.3
|
|
|
21.2
|
|
|
13.9
|
|
||||
Total revenues
|
686.6
|
|
|
654.8
|
|
|
1,389.2
|
|
|
1,288.8
|
|
||||
Expenses:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
357.6
|
|
|
370.1
|
|
|
725.2
|
|
|
730.3
|
|
||||
Amounts added to policyholder account balances:
|
|
|
|
|
|
|
|
||||||||
Cost of interest credited to policyholders
|
26.5
|
|
|
27.5
|
|
|
53.0
|
|
|
55.6
|
|
||||
Cost of options to fund index credits, net of forfeitures
|
16.2
|
|
|
16.6
|
|
|
31.1
|
|
|
33.5
|
|
||||
Market value changes credited to policyholders
|
19.0
|
|
|
2.6
|
|
|
61.2
|
|
|
(5.6
|
)
|
||||
Amortization related to operations
|
41.3
|
|
|
40.0
|
|
|
87.6
|
|
|
91.5
|
|
||||
Interest expense on investment borrowings
|
4.8
|
|
|
3.0
|
|
|
9.0
|
|
|
5.9
|
|
||||
Other operating costs and expenses
|
108.6
|
|
|
101.7
|
|
|
219.8
|
|
|
206.7
|
|
||||
Total benefits and expenses
|
574.0
|
|
|
561.5
|
|
|
1,186.9
|
|
|
1,117.9
|
|
||||
Income before net realized investment gains (losses), net of related amortization, and fair value changes in embedded derivative liabilities, net of related amortization, and income taxes
|
112.6
|
|
|
93.3
|
|
|
202.3
|
|
|
170.9
|
|
||||
Net realized investment gains (losses)
|
13.8
|
|
|
5.0
|
|
|
15.5
|
|
|
(1.6
|
)
|
||||
Amortization related to net realized investment gains (losses)
|
(.3
|
)
|
|
(.5
|
)
|
|
(.3
|
)
|
|
(.4
|
)
|
||||
Net realized investment gains (losses), net of related amortization
|
13.5
|
|
|
4.5
|
|
|
15.2
|
|
|
(2.0
|
)
|
||||
Insurance policy benefits - fair value changes in embedded derivative liabilities
|
(7.2
|
)
|
|
(20.6
|
)
|
|
(12.6
|
)
|
|
(57.3
|
)
|
||||
Amortization related to fair value changes in embedded derivative liabilities
|
1.3
|
|
|
4.2
|
|
|
2.3
|
|
|
11.8
|
|
||||
Fair value changes in embedded derivative liabilities, net of related amortization
|
(5.9
|
)
|
|
(16.4
|
)
|
|
(10.3
|
)
|
|
(45.5
|
)
|
||||
Income before income taxes
|
$
|
120.2
|
|
|
$
|
81.4
|
|
|
$
|
207.2
|
|
|
$
|
123.4
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Health benefit ratios:
|
|
|
|
|
|
|
|
||||||||
All health lines:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
$
|
281.2
|
|
|
$
|
300.6
|
|
|
$
|
571.7
|
|
|
$
|
595.0
|
|
Benefit ratio (a)
|
91.3
|
%
|
|
96.4
|
%
|
|
92.3
|
%
|
|
95.5
|
%
|
||||
Medicare supplement:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
$
|
136.9
|
|
|
$
|
141.2
|
|
|
$
|
274.1
|
|
|
$
|
278.2
|
|
Benefit ratio (a)
|
70.4
|
%
|
|
73.0
|
%
|
|
70.2
|
%
|
|
72.0
|
%
|
||||
Long-term care:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
$
|
144.3
|
|
|
$
|
159.4
|
|
|
$
|
297.6
|
|
|
$
|
316.8
|
|
Benefit ratio (a)
|
126.9
|
%
|
|
134.7
|
%
|
|
129.8
|
%
|
|
133.8
|
%
|
||||
Interest-adjusted benefit ratio (b)
|
66.2
|
%
|
|
77.9
|
%
|
|
69.4
|
%
|
|
76.6
|
%
|
(a)
|
We calculate benefit ratios by dividing the related product's insurance policy benefits by insurance policy income.
|
(b)
|
We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Bankers Life's long-term care products by dividing such product's insurance policy benefits less the imputed interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Commission expense and agent manager benefits
|
$
|
17.9
|
|
|
$
|
16.6
|
|
|
$
|
36.2
|
|
|
$
|
32.5
|
|
Other operating expenses
|
90.7
|
|
|
85.1
|
|
|
183.6
|
|
|
174.2
|
|
||||
Total
|
$
|
108.6
|
|
|
$
|
101.7
|
|
|
$
|
219.8
|
|
|
$
|
206.7
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Premium collections:
|
|
|
|
|
|
|
|
||||||||
Supplemental health and other health
|
$
|
147.4
|
|
|
$
|
142.2
|
|
|
$
|
298.0
|
|
|
$
|
283.8
|
|
Medicare supplement
|
12.6
|
|
|
15.1
|
|
|
27.0
|
|
|
31.5
|
|
||||
Life
|
7.3
|
|
|
7.4
|
|
|
15.2
|
|
|
14.6
|
|
||||
Annuity
|
.2
|
|
|
.5
|
|
|
.4
|
|
|
.8
|
|
||||
Total collections
|
$
|
167.5
|
|
|
$
|
165.2
|
|
|
$
|
340.6
|
|
|
$
|
330.7
|
|
Average liabilities for insurance products:
|
|
|
|
|
|
|
|
||||||||
Fixed index annuities
|
$
|
317.8
|
|
|
$
|
355.7
|
|
|
$
|
321.9
|
|
|
$
|
359.6
|
|
Fixed interest annuities
|
99.2
|
|
|
108.5
|
|
|
100.0
|
|
|
109.9
|
|
||||
SPIAs and supplemental contracts:
|
|
|
|
|
|
|
|
||||||||
Mortality based
|
232.3
|
|
|
250.9
|
|
|
232.9
|
|
|
249.7
|
|
||||
Deposit based
|
269.4
|
|
|
266.8
|
|
|
270.7
|
|
|
266.2
|
|
||||
Separate Accounts
|
4.6
|
|
|
4.6
|
|
|
4.6
|
|
|
4.7
|
|
||||
Health:
|
|
|
|
|
|
|
|
||||||||
Supplemental health
|
2,715.8
|
|
|
2,587.5
|
|
|
2,698.0
|
|
|
2,572.7
|
|
||||
Medicare supplement
|
25.4
|
|
|
28.4
|
|
|
26.1
|
|
|
28.9
|
|
||||
Other health
|
13.8
|
|
|
14.3
|
|
|
13.8
|
|
|
14.3
|
|
||||
Life:
|
|
|
|
|
|
|
|
||||||||
Interest sensitive
|
149.0
|
|
|
150.6
|
|
|
149.1
|
|
|
150.5
|
|
||||
Non-interest sensitive
|
173.2
|
|
|
180.5
|
|
|
174.3
|
|
|
181.4
|
|
||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$
|
4,000.5
|
|
|
$
|
3,947.8
|
|
|
$
|
3,991.4
|
|
|
$
|
3,937.9
|
|
Revenues:
|
|
|
|
|
|
|
|
||||||||
Insurance policy income
|
$
|
167.5
|
|
|
$
|
163.5
|
|
|
$
|
334.6
|
|
|
$
|
325.6
|
|
Net investment income:
|
|
|
|
|
|
|
|
||||||||
General account invested assets
|
64.8
|
|
|
62.6
|
|
|
128.2
|
|
|
124.3
|
|
||||
Fixed index products
|
1.2
|
|
|
—
|
|
|
3.8
|
|
|
(1.2
|
)
|
||||
Trading account income related to policyholder accounts
|
.5
|
|
|
1.0
|
|
|
1.9
|
|
|
1.1
|
|
||||
Fee revenue and other income
|
.2
|
|
|
.3
|
|
|
.5
|
|
|
.6
|
|
||||
Total revenues
|
234.2
|
|
|
227.4
|
|
|
469.0
|
|
|
450.4
|
|
||||
Expenses:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
139.9
|
|
|
137.8
|
|
|
277.7
|
|
|
266.9
|
|
||||
Amounts added to policyholder account balances:
|
|
|
|
|
|
|
|
||||||||
Cost of interest credited to policyholders
|
3.2
|
|
|
3.5
|
|
|
6.5
|
|
|
7.0
|
|
||||
Cost of options to fund index credits, net of forfeitures
|
1.0
|
|
|
1.5
|
|
|
2.0
|
|
|
3.2
|
|
||||
Market value changes credited to policyholders
|
1.2
|
|
|
1.2
|
|
|
5.8
|
|
|
.4
|
|
||||
Amortization related to operations
|
15.3
|
|
|
15.1
|
|
|
29.6
|
|
|
30.2
|
|
||||
Interest expense on investment borrowings
|
1.5
|
|
|
.8
|
|
|
2.8
|
|
|
1.6
|
|
||||
Other operating costs and expenses
|
48.5
|
|
|
46.0
|
|
|
97.5
|
|
|
93.3
|
|
||||
Total benefits and expenses
|
210.6
|
|
|
205.9
|
|
|
421.9
|
|
|
402.6
|
|
||||
Income before net realized investment gains (losses) and fair value changes in embedded derivative liabilities, net of related amortization, and income taxes
|
23.6
|
|
|
21.5
|
|
|
47.1
|
|
|
47.8
|
|
||||
Net realized investment gains (losses)
|
4.1
|
|
|
13.9
|
|
|
6.1
|
|
|
27.1
|
|
||||
Amortization related to net realized investment gains (losses)
|
—
|
|
|
(.1
|
)
|
|
—
|
|
|
(.3
|
)
|
||||
Net realized investment gains (losses), net of related amortization
|
4.1
|
|
|
13.8
|
|
|
6.1
|
|
|
26.8
|
|
||||
Insurance policy benefits - fair value changes in embedded derivative liabilities
|
—
|
|
|
(.5
|
)
|
|
(.1
|
)
|
|
(1.8
|
)
|
||||
Amortization related to fair value changes in embedded derivative liabilities
|
—
|
|
|
.4
|
|
|
.1
|
|
|
1.3
|
|
||||
Fair value changes in embedded derivative liabilities, net of related amortization
|
—
|
|
|
(.1
|
)
|
|
—
|
|
|
(.5
|
)
|
||||
Income before income taxes
|
$
|
27.7
|
|
|
$
|
35.2
|
|
|
$
|
53.2
|
|
|
$
|
74.1
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Health benefit ratios:
|
|
|
|
|
|
|
|
||||||||
Medicare supplement:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
$
|
9.7
|
|
|
$
|
11.7
|
|
|
$
|
19.2
|
|
|
$
|
22.3
|
|
Benefit ratio (a)
|
70.4
|
%
|
|
74.0
|
%
|
|
68.6
|
%
|
|
69.5
|
%
|
||||
Supplemental health and other:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
$
|
123.6
|
|
|
$
|
120.8
|
|
|
$
|
246.8
|
|
|
$
|
233.8
|
|
Benefit ratio (a)
|
84.5
|
%
|
|
85.7
|
%
|
|
84.5
|
%
|
|
83.5
|
%
|
||||
Interest-adjusted benefit ratio (b)
|
60.4
|
%
|
|
61.6
|
%
|
|
60.5
|
%
|
|
59.7
|
%
|
(a)
|
We calculate benefit ratios by dividing the related product’s insurance policy benefits by insurance policy income.
|
(b)
|
We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Washington National's supplemental health products by dividing such product’s insurance policy benefits less the imputed interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Premium collections:
|
|
|
|
|
|
|
|
||||||||
Life
|
$
|
71.9
|
|
|
$
|
69.0
|
|
|
$
|
145.9
|
|
|
$
|
138.5
|
|
Supplemental health
|
.6
|
|
|
.6
|
|
|
1.1
|
|
|
1.2
|
|
||||
Total collections
|
$
|
72.5
|
|
|
$
|
69.6
|
|
|
$
|
147.0
|
|
|
$
|
139.7
|
|
Average liabilities for insurance products:
|
|
|
|
|
|
|
|
||||||||
SPIAs - mortality based
|
$
|
72.7
|
|
|
$
|
74.3
|
|
|
$
|
72.6
|
|
|
$
|
72.7
|
|
Health:
|
|
|
|
|
|
|
|
||||||||
Medicare supplement
|
5.7
|
|
|
6.6
|
|
|
5.9
|
|
|
6.7
|
|
||||
Other health
|
4.1
|
|
|
4.3
|
|
|
4.1
|
|
|
4.3
|
|
||||
Life:
|
|
|
|
|
|
|
|
||||||||
Interest sensitive
|
15.6
|
|
|
16.2
|
|
|
15.7
|
|
|
16.2
|
|
||||
Non-interest sensitive
|
714.9
|
|
|
684.7
|
|
|
711.5
|
|
|
682.7
|
|
||||
Total average liabilities for insurance products, net of reinsurance ceded
|
$
|
813.0
|
|
|
$
|
786.1
|
|
|
$
|
809.8
|
|
|
$
|
782.6
|
|
Revenues:
|
|
|
|
|
|
|
|
||||||||
Insurance policy income
|
$
|
73.0
|
|
|
$
|
70.5
|
|
|
$
|
146.0
|
|
|
$
|
139.6
|
|
Net investment income on general account invested assets
|
11.2
|
|
|
10.9
|
|
|
22.1
|
|
|
21.9
|
|
||||
Fee revenue and other income
|
.4
|
|
|
.2
|
|
|
.6
|
|
|
.6
|
|
||||
Total revenues
|
84.6
|
|
|
81.6
|
|
|
168.7
|
|
|
162.1
|
|
||||
Expenses:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
50.2
|
|
|
50.3
|
|
|
102.8
|
|
|
100.7
|
|
||||
Amounts added to annuity and interest-sensitive life product account balances
|
.2
|
|
|
.2
|
|
|
.3
|
|
|
.3
|
|
||||
Amortization related to operations
|
4.0
|
|
|
3.7
|
|
|
8.0
|
|
|
7.6
|
|
||||
Interest expense on investment borrowings
|
.2
|
|
|
.2
|
|
|
.4
|
|
|
.3
|
|
||||
Other operating costs and expenses
|
22.0
|
|
|
24.2
|
|
|
49.5
|
|
|
57.0
|
|
||||
Total benefits and expenses
|
76.6
|
|
|
78.6
|
|
|
161.0
|
|
|
165.9
|
|
||||
Income (loss) before net realized investment gains (losses) and income taxes
|
8.0
|
|
|
3.0
|
|
|
7.7
|
|
|
(3.8
|
)
|
||||
Net realized investment gains (losses)
|
(.1
|
)
|
|
.7
|
|
|
(.2
|
)
|
|
(.5
|
)
|
||||
Income (loss) before income taxes
|
$
|
7.9
|
|
|
$
|
3.7
|
|
|
$
|
7.5
|
|
|
$
|
(4.3
|
)
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Adjusted EBIT from In-Force Business
|
|
|
|
|
|
|
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Insurance policy income
|
$
|
60.2
|
|
|
$
|
56.5
|
|
|
$
|
119.8
|
|
|
$
|
111.8
|
|
Net investment income and other
|
11.6
|
|
|
11.1
|
|
|
22.7
|
|
|
22.5
|
|
||||
Total revenues
|
71.8
|
|
|
67.6
|
|
|
142.5
|
|
|
134.3
|
|
||||
Benefits and expenses:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
42.6
|
|
|
42.0
|
|
|
87.2
|
|
|
84.1
|
|
||||
Amortization
|
3.8
|
|
|
3.5
|
|
|
7.6
|
|
|
7.2
|
|
||||
Other expenses
|
8.0
|
|
|
8.0
|
|
|
16.2
|
|
|
16.2
|
|
||||
Total benefits and expenses
|
54.4
|
|
|
53.5
|
|
|
111.0
|
|
|
107.5
|
|
||||
Adjusted EBIT from In-Force Business
|
$
|
17.4
|
|
|
$
|
14.1
|
|
|
$
|
31.5
|
|
|
$
|
26.8
|
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBIT from New Business
|
|
|
|
|
|
|
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Insurance policy income
|
$
|
12.8
|
|
|
$
|
14.0
|
|
|
$
|
26.2
|
|
|
$
|
27.8
|
|
Net investment income and other
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total revenues
|
12.8
|
|
|
14.0
|
|
|
26.2
|
|
|
27.8
|
|
||||
Benefits and expenses:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
7.8
|
|
|
8.5
|
|
|
15.9
|
|
|
16.9
|
|
||||
Amortization
|
.2
|
|
|
.2
|
|
|
.4
|
|
|
.4
|
|
||||
Other expenses
|
14.2
|
|
|
16.4
|
|
|
33.7
|
|
|
41.1
|
|
||||
Total benefits and expenses
|
22.2
|
|
|
25.1
|
|
|
50.0
|
|
|
58.4
|
|
||||
Adjusted EBIT from New Business
|
$
|
(9.4
|
)
|
|
$
|
(11.1
|
)
|
|
$
|
(23.8
|
)
|
|
$
|
(30.6
|
)
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBIT from In-Force and New Business
|
|
|
|
|
|
|
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Insurance policy income
|
$
|
73.0
|
|
|
$
|
70.5
|
|
|
$
|
146.0
|
|
|
$
|
139.6
|
|
Net investment income and other
|
11.6
|
|
|
11.1
|
|
|
22.7
|
|
|
22.5
|
|
||||
Total revenues
|
84.6
|
|
|
81.6
|
|
|
168.7
|
|
|
162.1
|
|
||||
Benefits and expenses:
|
|
|
|
|
|
|
|
||||||||
Insurance policy benefits
|
50.4
|
|
|
50.5
|
|
|
103.1
|
|
|
101.0
|
|
||||
Amortization
|
4.0
|
|
|
3.7
|
|
|
8.0
|
|
|
7.6
|
|
||||
Other expenses
|
22.2
|
|
|
24.4
|
|
|
49.9
|
|
|
57.3
|
|
||||
Total benefits and expenses
|
76.6
|
|
|
78.6
|
|
|
161.0
|
|
|
165.9
|
|
||||
Adjusted EBIT from In-Force and New Business
|
$
|
8.0
|
|
|
$
|
3.0
|
|
|
$
|
7.7
|
|
|
$
|
(3.8
|
)
|
|
Three months ended
|
|
Six months ended
|
||||
|
June 30, 2017
|
|
June 30, 2017
|
||||
Premium collections:
|
|
|
|
||||
Long-term care (all renewal)
|
$
|
4.4
|
|
|
$
|
9.0
|
|
|
|
|
|
||||
Average liabilities for insurance products:
|
|
|
|
||||
Average liabilities for long-term care products
|
$
|
573.2
|
|
|
$
|
566.9
|
|
|
|
|
|
||||
Revenues:
|
|
|
|
||||
Insurance policy income
|
$
|
4.5
|
|
|
$
|
9.1
|
|
Net investment income on general account invested assets
|
10.0
|
|
|
19.7
|
|
||
Total revenues
|
14.5
|
|
|
28.8
|
|
||
Expenses:
|
|
|
|
||||
Insurance policy benefits
|
12.0
|
|
|
25.2
|
|
||
Other operating costs and expenses
|
.8
|
|
|
1.5
|
|
||
Total benefits and expenses
|
12.8
|
|
|
26.7
|
|
||
Income before net realized investment gains and income taxes
|
1.7
|
|
|
2.1
|
|
||
Net realized investment gains
|
1.4
|
|
|
1.1
|
|
||
Income before income taxes
|
$
|
3.1
|
|
|
$
|
3.2
|
|
|
Three months ended
|
|
Six months ended
|
||||
|
June 30, 2017
|
|
June 30, 2017
|
||||
Health benefit ratios:
|
|
|
|
||||
Long-term care:
|
|
|
|
||||
Insurance policy benefits
|
$
|
12.0
|
|
|
$
|
25.2
|
|
Benefit ratio (a)
|
268.2
|
%
|
|
277.5
|
%
|
||
Interest-adjusted benefit ratio (b)
|
104.6
|
%
|
|
116.6
|
%
|
(a)
|
We calculate benefit ratios by dividing the related product's insurance policy benefits by insurance policy income.
|
(b)
|
We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for long-term care products in this segment by dividing such product's insurance policy benefits less the imputed interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Corporate operations:
|
|
|
|
|
|
|
|
||||||||
Interest expense on corporate debt
|
$
|
(11.6
|
)
|
|
$
|
(11.4
|
)
|
|
$
|
(23.1
|
)
|
|
$
|
(22.8
|
)
|
Net investment income (loss):
|
|
|
|
|
|
|
|
||||||||
General investment portfolio
|
1.4
|
|
|
1.6
|
|
|
2.3
|
|
|
2.9
|
|
||||
Other special-purpose portfolios:
|
|
|
|
|
|
|
|
||||||||
COLI
|
2.9
|
|
|
.6
|
|
|
9.3
|
|
|
(.3
|
)
|
||||
Investments held in a rabbi trust
|
.7
|
|
|
.3
|
|
|
1.5
|
|
|
.4
|
|
||||
Other trading account activities
|
2.4
|
|
|
3.4
|
|
|
4.7
|
|
|
6.9
|
|
||||
Fee revenue and other income
|
2.3
|
|
|
2.6
|
|
|
4.7
|
|
|
5.1
|
|
||||
Other operating costs and expenses
|
(22.9
|
)
|
|
(15.5
|
)
|
|
(44.6
|
)
|
|
(30.1
|
)
|
||||
Loss before net realized investment gains (losses), earnings attributable to VIEs, fair value changes related to agent deferred compensation plan and income taxes
|
(24.8
|
)
|
|
(18.4
|
)
|
|
(45.2
|
)
|
|
(37.9
|
)
|
||||
Net realized investment gains (losses)
|
(4.0
|
)
|
|
(7.0
|
)
|
|
.6
|
|
|
(13.3
|
)
|
||||
Earnings attributable to VIEs
|
(1.6
|
)
|
|
.1
|
|
|
(1.3
|
)
|
|
(.5
|
)
|
||||
Fair value changes related to agent deferred compensation plan
|
—
|
|
|
(12.3
|
)
|
|
—
|
|
|
(18.3
|
)
|
||||
Loss before income taxes
|
$
|
(30.4
|
)
|
|
$
|
(37.6
|
)
|
|
$
|
(45.9
|
)
|
|
$
|
(70.0
|
)
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
First year:
|
|
|
|
|
|
|
|
||||||||
Bankers Life
|
$
|
319.9
|
|
|
$
|
270.4
|
|
|
$
|
631.0
|
|
|
$
|
564.9
|
|
Washington National
|
19.7
|
|
|
19.8
|
|
|
40.2
|
|
|
39.9
|
|
||||
Colonial Penn
|
12.7
|
|
|
13.8
|
|
|
26.4
|
|
|
27.8
|
|
||||
Total first year
|
352.3
|
|
|
304.0
|
|
|
697.6
|
|
|
632.6
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Renewal:
|
|
|
|
|
|
|
|
||||||||
Bankers Life
|
360.7
|
|
|
357.8
|
|
|
737.4
|
|
|
724.0
|
|
||||
Washington National
|
147.8
|
|
|
145.4
|
|
|
300.4
|
|
|
290.8
|
|
||||
Colonial Penn
|
59.8
|
|
|
55.8
|
|
|
120.6
|
|
|
111.9
|
|
||||
Long-term care in run-off
|
4.4
|
|
|
—
|
|
|
9.0
|
|
|
—
|
|
||||
Total renewal
|
572.7
|
|
|
559.0
|
|
|
1,167.4
|
|
|
1,126.7
|
|
||||
Total premiums collected
|
$
|
925.0
|
|
|
$
|
863.0
|
|
|
$
|
1,865.0
|
|
|
$
|
1,759.3
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Premiums collected by product:
|
|
|
|
|
|
|
|
||||||||
Annuities:
|
|
|
|
|
|
|
|
||||||||
Fixed index (first-year)
|
$
|
247.2
|
|
|
$
|
179.6
|
|
|
$
|
482.5
|
|
|
$
|
379.5
|
|
Other fixed interest (first-year)
|
15.1
|
|
|
25.5
|
|
|
35.7
|
|
|
57.4
|
|
||||
Other fixed interest (renewal)
|
2.0
|
|
|
1.3
|
|
|
3.6
|
|
|
3.1
|
|
||||
Subtotal - other fixed interest annuities
|
17.1
|
|
|
26.8
|
|
|
39.3
|
|
|
60.5
|
|
||||
Total annuities
|
264.3
|
|
|
206.4
|
|
|
521.8
|
|
|
440.0
|
|
||||
Health:
|
|
|
|
|
|
|
|
||||||||
Medicare supplement (first-year)
|
17.6
|
|
|
19.1
|
|
|
35.1
|
|
|
37.5
|
|
||||
Medicare supplement (renewal)
|
162.1
|
|
|
159.9
|
|
|
336.3
|
|
|
328.4
|
|
||||
Subtotal - Medicare supplement
|
179.7
|
|
|
179.0
|
|
|
371.4
|
|
|
365.9
|
|
||||
Long-term care (first-year)
|
4.1
|
|
|
4.4
|
|
|
8.3
|
|
|
8.8
|
|
||||
Long-term care (renewal)
|
108.0
|
|
|
113.6
|
|
|
220.8
|
|
|
228.8
|
|
||||
Subtotal - long-term care
|
112.1
|
|
|
118.0
|
|
|
229.1
|
|
|
237.6
|
|
||||
Supplemental health (first-year)
|
1.3
|
|
|
1.4
|
|
|
2.7
|
|
|
2.7
|
|
||||
Supplemental health (renewal)
|
4.3
|
|
|
3.9
|
|
|
8.6
|
|
|
7.6
|
|
||||
Subtotal – supplemental health
|
5.6
|
|
|
5.3
|
|
|
11.3
|
|
|
10.3
|
|
||||
Other health (first-year)
|
.2
|
|
|
—
|
|
|
.4
|
|
|
—
|
|
||||
Other health (renewal)
|
1.3
|
|
|
1.6
|
|
|
2.7
|
|
|
3.2
|
|
||||
Subtotal - other health
|
1.5
|
|
|
1.6
|
|
|
3.1
|
|
|
3.2
|
|
||||
Total health
|
298.9
|
|
|
303.9
|
|
|
614.9
|
|
|
617.0
|
|
||||
Life insurance:
|
|
|
|
|
|
|
|
||||||||
Traditional (first-year)
|
22.1
|
|
|
22.2
|
|
|
42.3
|
|
|
43.0
|
|
||||
Traditional (renewal)
|
54.3
|
|
|
52.0
|
|
|
108.4
|
|
|
102.2
|
|
||||
Subtotal - traditional
|
76.4
|
|
|
74.2
|
|
|
150.7
|
|
|
145.2
|
|
||||
Interest-sensitive (first-year)
|
12.3
|
|
|
18.2
|
|
|
24.0
|
|
|
36.0
|
|
||||
Interest-sensitive (renewal)
|
28.7
|
|
|
25.5
|
|
|
57.0
|
|
|
50.7
|
|
||||
Subtotal - interest-sensitive
|
41.0
|
|
|
43.7
|
|
|
81.0
|
|
|
86.7
|
|
||||
Total life insurance
|
117.4
|
|
|
117.9
|
|
|
231.7
|
|
|
231.9
|
|
||||
Collections on insurance products:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total first-year premium collections on insurance products
|
319.9
|
|
|
270.4
|
|
|
631.0
|
|
|
564.9
|
|
||||
Total renewal premium collections on insurance products
|
360.7
|
|
|
357.8
|
|
|
737.4
|
|
|
724.0
|
|
||||
Total collections on insurance products
|
$
|
680.6
|
|
|
$
|
628.2
|
|
|
$
|
1,368.4
|
|
|
$
|
1,288.9
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Premiums collected by product:
|
|
|
|
|
|
|
|
||||||||
Health:
|
|
|
|
|
|
|
|
||||||||
Medicare supplement (renewal)
|
$
|
12.6
|
|
|
$
|
15.1
|
|
|
$
|
27.0
|
|
|
$
|
31.5
|
|
Supplemental health (first-year)
|
18.4
|
|
|
18.3
|
|
|
37.4
|
|
|
36.8
|
|
||||
Supplemental health (renewal)
|
128.6
|
|
|
123.5
|
|
|
259.7
|
|
|
246.1
|
|
||||
Subtotal – supplemental health
|
147.0
|
|
|
141.8
|
|
|
297.1
|
|
|
282.9
|
|
||||
Other health (first-year)
|
—
|
|
|
.1
|
|
|
.1
|
|
|
.1
|
|
||||
Other health (renewal)
|
.4
|
|
|
.3
|
|
|
.8
|
|
|
.8
|
|
||||
Subtotal - other health
|
.4
|
|
|
.4
|
|
|
.9
|
|
|
.9
|
|
||||
Total health
|
160.0
|
|
|
157.3
|
|
|
325.0
|
|
|
315.3
|
|
||||
Life insurance:
|
|
|
|
|
|
|
|
||||||||
Traditional (first-year)
|
.2
|
|
|
.2
|
|
|
.4
|
|
|
.4
|
|
||||
Traditional (renewal)
|
2.6
|
|
|
2.8
|
|
|
5.2
|
|
|
5.4
|
|
||||
Subtotal - traditional
|
2.8
|
|
|
3.0
|
|
|
5.6
|
|
|
5.8
|
|
||||
Interest-sensitive (first-year)
|
1.1
|
|
|
1.2
|
|
|
2.3
|
|
|
2.6
|
|
||||
Interest-sensitive (renewal)
|
3.4
|
|
|
3.2
|
|
|
7.3
|
|
|
6.2
|
|
||||
Subtotal - interest-sensitive
|
4.5
|
|
|
4.4
|
|
|
9.6
|
|
|
8.8
|
|
||||
Total life insurance
|
7.3
|
|
|
7.4
|
|
|
15.2
|
|
|
14.6
|
|
||||
Annuities:
|
|
|
|
|
|
|
|
||||||||
Fixed index (renewal)
|
.1
|
|
|
.4
|
|
|
.3
|
|
|
.6
|
|
||||
Other fixed interest (renewal)
|
.1
|
|
|
.1
|
|
|
.1
|
|
|
.2
|
|
||||
Total annuities
|
.2
|
|
|
.5
|
|
|
.4
|
|
|
.8
|
|
||||
Collections on insurance products:
|
|
|
|
|
|
|
|
||||||||
Total first-year premium collections on insurance products
|
19.7
|
|
|
19.8
|
|
|
40.2
|
|
|
39.9
|
|
||||
Total renewal premium collections on insurance products
|
147.8
|
|
|
145.4
|
|
|
300.4
|
|
|
290.8
|
|
||||
Total collections on insurance products
|
$
|
167.5
|
|
|
$
|
165.2
|
|
|
$
|
340.6
|
|
|
$
|
330.7
|
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Premiums collected by product:
|
|
|
|
|
|
|
|
||||||||
Life insurance:
|
|
|
|
|
|
|
|
||||||||
Traditional (first-year)
|
$
|
12.7
|
|
|
$
|
13.8
|
|
|
$
|
26.4
|
|
|
$
|
27.8
|
|
Traditional (renewal)
|
59.2
|
|
|
55.1
|
|
|
119.4
|
|
|
110.5
|
|
||||
Subtotal - traditional
|
71.9
|
|
|
68.9
|
|
|
145.8
|
|
|
138.3
|
|
||||
Interest-sensitive (all renewal)
|
—
|
|
|
.1
|
|
|
.1
|
|
|
.2
|
|
||||
Total life insurance
|
71.9
|
|
|
69.0
|
|
|
145.9
|
|
|
138.5
|
|
||||
Health (all renewal):
|
|
|
|
|
|
|
|
||||||||
Medicare supplement
|
.5
|
|
|
.6
|
|
|
1.0
|
|
|
1.1
|
|
||||
Other health
|
.1
|
|
|
—
|
|
|
.1
|
|
|
.1
|
|
||||
Total health
|
.6
|
|
|
.6
|
|
|
1.1
|
|
|
1.2
|
|
||||
Collections on insurance products:
|
|
|
|
|
|
|
|
||||||||
Total first-year premium collections on insurance products
|
12.7
|
|
|
13.8
|
|
|
26.4
|
|
|
27.8
|
|
||||
Total renewal premium collections on insurance products
|
59.8
|
|
|
55.8
|
|
|
120.6
|
|
|
111.9
|
|
||||
Total collections on insurance products
|
$
|
72.5
|
|
|
$
|
69.6
|
|
|
$
|
147.0
|
|
|
$
|
139.7
|
|
|
Three months ended
|
|
Six months ended
|
||||
|
June 30, 2017
|
|
June 30, 2017
|
||||
Premiums collected by product:
|
|
|
|
||||
Health:
|
|
|
|
||||
Long-term care (renewal)
|
$
|
4.4
|
|
|
$
|
9.0
|
|
|
June 30,
2017 |
|
December 31, 2016
|
||||
Total capital:
|
|
|
|
||||
Corporate notes payable
|
$
|
913.9
|
|
|
$
|
912.9
|
|
Shareholders’ equity:
|
|
|
|
|
|||
Common stock
|
1.7
|
|
|
1.7
|
|
||
Additional paid-in capital
|
3,116.7
|
|
|
3,212.1
|
|
||
Accumulated other comprehensive income
|
894.5
|
|
|
622.4
|
|
||
Retained earnings
|
766.4
|
|
|
650.7
|
|
||
Total shareholders’ equity
|
4,779.3
|
|
|
4,486.9
|
|
||
Total capital
|
$
|
5,693.2
|
|
|
$
|
5,399.8
|
|
|
June 30,
2017 |
|
December 31, 2016
|
||||
Book value per common share
|
$
|
28.28
|
|
|
$
|
25.82
|
|
Book value per common share, excluding accumulated other comprehensive income (a)
|
22.98
|
|
|
22.24
|
|
||
Ratio of earnings to fixed charges
|
2.81X
|
|
|
2.43X
|
|
||
Debt to total capital ratios:
|
|
|
|
||||
Corporate debt to total capital
|
16.1
|
%
|
|
16.9
|
%
|
||
Corporate debt to total capital, excluding accumulated other comprehensive income (a)
|
19.0
|
%
|
|
19.1
|
%
|
(a)
|
This non-GAAP measure differs from the corresponding GAAP measure presented immediately above, because accumulated other comprehensive income has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income. Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. However, this measure does not replace the corresponding GAAP measure.
|
|
|
|
|
|
|
Investments not included in scope of audit
|
|
|
||||||||
|
|
Investments included in initial scope of audit
|
|
Investments included in additional scope of audit
|
|
Cash, fixed maturities and other invested assets
|
|
Total investments
|
||||||||
September 30, 2016 values
|
|
$
|
62.2
|
|
|
$
|
62.6
|
|
|
$
|
379.8
|
|
|
$
|
504.6
|
|
Net cash flows (1)
|
|
(13.5
|
)
|
|
(11.6
|
)
|
|
(359.5
|
)
|
|
(384.6
|
)
|
||||
Realized gains (losses) and impairments (2)
|
|
.4
|
|
|
(1.7
|
)
|
|
(4.0
|
)
|
|
(5.3
|
)
|
||||
Other activity (5)
|
|
3.9
|
|
|
1.9
|
|
|
.6
|
|
|
6.4
|
|
||||
December 31, 2016 values
|
|
53.0
|
|
|
51.2
|
|
|
16.9
|
|
|
121.1
|
|
||||
Net cash flows (1)
|
|
(16.7
|
)
|
|
(5.5
|
)
|
|
(8.7
|
)
|
|
(30.9
|
)
|
||||
Realized gains (losses) and impairments (3)
|
|
3.2
|
|
|
(4.5
|
)
|
|
1.0
|
|
|
(.3
|
)
|
||||
Other activity (5)
|
|
(1.8
|
)
|
|
1.3
|
|
|
(1.4
|
)
|
|
(1.9
|
)
|
||||
March 31, 2017 values
|
|
37.7
|
|
|
42.5
|
|
|
7.8
|
|
|
88.0
|
|
||||
Net cash flows (1)
|
|
.5
|
|
|
(14.4
|
)
|
|
—
|
|
|
(13.9
|
)
|
||||
Realized gains (losses) and impairments (4)
|
|
(3.1
|
)
|
|
4.5
|
|
|
—
|
|
|
1.4
|
|
||||
Other activity (5)
|
|
(.6
|
)
|
|
(.4
|
)
|
|
.3
|
|
|
(.7
|
)
|
||||
June 30, 2017 values
|
|
$
|
34.5
|
|
|
$
|
32.2
|
|
|
$
|
8.1
|
|
|
$
|
74.8
|
|
|
|
Investments included in initial scope of audit
|
|
Investments included in additional scope of audit
|
|
Total investments included in the scope of audit
|
||||||
Lease related investments
|
$
|
—
|
|
|
$
|
19.2
|
|
|
$
|
19.2
|
|
|
Mortgage loans secured by real estate
|
1.1
|
|
|
10.6
|
|
|
11.7
|
|
||||
Senior secured loans to companies in the energy sector (6)
|
11.3
|
|
|
—
|
|
|
11.3
|
|
||||
Senior secured loans to other companies
|
14.0
|
|
|
.5
|
|
|
14.5
|
|
||||
Secured term loan issued by Platinum Partners Credit Opportunity Master Fund L.P.
|
5.4
|
|
|
—
|
|
|
5.4
|
|
||||
Preferred and common stock
|
2.7
|
|
|
.3
|
|
|
3.0
|
|
||||
Other
|
—
|
|
|
1.6
|
|
|
1.6
|
|
||||
Total investments
|
$
|
34.5
|
|
|
$
|
32.2
|
|
|
$
|
66.7
|
|
(1)
|
Net cash inflows from sales and redemptions of investments during the period.
|
(2)
|
Includes $4.6 million of impairment charges and $.7 million of net realized losses recognized on the sale of transferred investments.
|
(3)
|
Includes $8.4 million of impairment charges; partially offset by $8.1 million of net realized gains recognized on the sale of transferred investments.
|
(4)
|
Includes $3.7 million of impairment charges; and $5.1 million of net realized gains recognized on the sale of transferred investments.
|
(5)
|
Includes amortization of discount and premium and changes in estimated fair values of investments during the period.
|
(6)
|
Includes: (i) $2.5 million of loans issued by Golden Gate Oil, LLC with a par value of $11.7 million; and (ii) $6.8 million of loans issued by the parent of Agera Energy LLC with a par value of $11.4 million. The issuers of this debt have been referred to in recent articles regarding Platinum.
|
Amount
|
|
Maturity
|
|
Interest rate at
|
||
borrowed
|
|
date
|
|
June 30, 2017
|
||
$
|
50.0
|
|
|
January 2018
|
|
Variable rate – 1.508%
|
50.0
|
|
|
January 2018
|
|
Variable rate – 1.493%
|
|
50.0
|
|
|
February 2018
|
|
Variable rate – 1.489%
|
|
50.0
|
|
|
February 2018
|
|
Variable rate – 1.270%
|
|
50.0
|
|
|
July 2018
|
|
Variable rate – 1.642%
|
|
50.0
|
|
|
August 2018
|
|
Variable rate – 1.302%
|
|
50.0
|
|
|
January 2019
|
|
Variable rate – 1.578%
|
|
50.0
|
|
|
February 2019
|
|
Variable rate – 1.270%
|
|
100.0
|
|
|
March 2019
|
|
Variable rate – 1.689%
|
|
21.8
|
|
|
July 2019
|
|
Variable rate – 1.500%
|
|
15.0
|
|
|
October 2019
|
|
Variable rate – 1.683%
|
|
50.0
|
|
|
May 2020
|
|
Variable rate – 1.679%
|
|
21.8
|
|
|
June 2020
|
|
Fixed rate – 1.960%
|
|
25.0
|
|
|
September 2020
|
|
Variable rate – 1.921%
|
|
100.0
|
|
|
September 2020
|
|
Variable rate – 1.876%
|
|
50.0
|
|
|
September 2020
|
|
Variable rate – 1.882%
|
|
75.0
|
|
|
September 2020
|
|
Variable rate – 1.416%
|
|
100.0
|
|
|
October 2020
|
|
Variable rate – 1.260%
|
|
50.0
|
|
|
December 2020
|
|
Variable rate – 1.776%
|
|
100.0
|
|
|
July 2021
|
|
Variable rate – 1.708%
|
|
100.0
|
|
|
July 2021
|
|
Variable rate – 1.678%
|
|
28.2
|
|
|
August 2021
|
|
Fixed rate – 2.550%
|
|
57.7
|
|
|
August 2021
|
|
Variable rate - 1.701%
|
|
125.0
|
|
|
August 2021
|
|
Variable rate – 1.696%
|
|
50.0
|
|
|
September 2021
|
|
Variable rate – 1.738%
|
|
22.0
|
|
|
May 2022
|
|
Variable rate – 1.550%
|
|
100.0
|
|
|
May 2022
|
|
Variable rate – 1.656%
|
|
10.0
|
|
|
June 2022
|
|
Variable rate – 1.850%
|
|
25.0
|
|
|
March 2023
|
|
Fixed rate – 2.160%
|
|
20.5
|
|
|
June 2025
|
|
Fixed rate – 2.940%
|
|
$
|
1,647.0
|
|
|
|
|
|
Subsidiaries of CLTX
|
|
Earned surplus (deficit)
|
|
Additional information
|
||
Bankers Life
|
|
$
|
580.7
|
|
|
(a)
|
Colonial Penn
|
|
(297.0
|
)
|
|
(b)
|
(a)
|
Bankers Life paid dividends of $86.0 million to CLTX in the first
six
months of
2017
.
|
(b)
|
The deficit is primarily due to transactions which occurred several years ago, including a tax planning transaction and the fee paid to recapture a block of business previously ceded to an unaffiliated insurer.
|
|
Amortized
cost
|
|
Gross
unrealized
gains
|
|
Gross
unrealized
losses
|
|
Estimated
fair
value
|
||||||||
Investment grade (a):
|
|
|
|
|
|
|
|
||||||||
Corporate securities
|
$
|
12,102.4
|
|
|
$
|
1,482.8
|
|
|
$
|
(25.4
|
)
|
|
$
|
13,559.8
|
|
United States Treasury securities and obligations of United States government corporations and agencies
|
174.4
|
|
|
27.8
|
|
|
—
|
|
|
202.2
|
|
||||
States and political subdivisions
|
1,853.0
|
|
|
217.2
|
|
|
(2.5
|
)
|
|
2,067.7
|
|
||||
Debt securities issued by foreign governments
|
55.3
|
|
|
1.7
|
|
|
(.1
|
)
|
|
56.9
|
|
||||
Asset-backed securities
|
1,189.4
|
|
|
38.4
|
|
|
(2.5
|
)
|
|
1,225.3
|
|
||||
Collateralized debt obligations
|
223.6
|
|
|
1.3
|
|
|
—
|
|
|
224.9
|
|
||||
Commercial mortgage-backed securities
|
1,308.9
|
|
|
37.0
|
|
|
(13.7
|
)
|
|
1,332.2
|
|
||||
Mortgage pass-through securities
|
2.1
|
|
|
.2
|
|
|
—
|
|
|
2.3
|
|
||||
Collateralized mortgage obligations
|
341.3
|
|
|
18.1
|
|
|
(.8
|
)
|
|
358.6
|
|
||||
Total investment grade fixed maturities, available for sale
|
17,250.4
|
|
|
1,824.5
|
|
|
(45.0
|
)
|
|
19,029.9
|
|
||||
Below-investment grade (a) (b):
|
|
|
|
|
|
|
|
|
|
|
|
||||
Corporate securities
|
858.2
|
|
|
25.7
|
|
|
(24.7
|
)
|
|
859.2
|
|
||||
States and political subdivisions
|
3.0
|
|
|
—
|
|
|
—
|
|
|
3.0
|
|
||||
Asset-backed securities
|
1,508.9
|
|
|
110.6
|
|
|
(1.4
|
)
|
|
1,618.1
|
|
||||
Collateralized debt obligations
|
2.5
|
|
|
—
|
|
|
—
|
|
|
2.5
|
|
||||
Commercial mortgage-backed securities
|
55.8
|
|
|
.5
|
|
|
(1.1
|
)
|
|
55.2
|
|
||||
Collateralized mortgage obligations
|
450.1
|
|
|
53.8
|
|
|
(.4
|
)
|
|
503.5
|
|
||||
Total below-investment grade fixed maturities, available for sale
|
2,878.5
|
|
|
190.6
|
|
|
(27.6
|
)
|
|
3,041.5
|
|
||||
Total fixed maturities, available for sale
|
$
|
20,128.9
|
|
|
$
|
2,015.1
|
|
|
$
|
(72.6
|
)
|
|
$
|
22,071.4
|
|
(a)
|
Investment ratings – Investment ratings are assigned the second lowest rating by Nationally Recognized Statistical Rating Organizations ("NRSROs") (Moody's, S&P or Fitch), or if not rated by such firms, the rating assigned by the National Association of Insurance Commissioners (the "NAIC"). NAIC designations of "1" or "2" include fixed maturities generally rated investment grade (rated "Baa3" or higher by Moody's or rated "BBB-" or higher by S&P and Fitch). NAIC designations of "3" through "6" are referred to as below-investment grade (which generally are rated "Ba1" or lower by Moody's or rated "BB+" or lower by S&P and Fitch). References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.
|
(b)
|
Certain structured securities rated below-investment grade by NRSROs may be assigned a NAIC 1 or NAIC 2 designation based on the cost basis of the security relative to estimated recoverable amounts as determined by the NAIC. Refer to the table on the page which follows for a summary of our fixed maturity securities, available for sale, by NAIC designations.
|
NAIC Designation
|
|
NRSRO Equivalent Rating
|
1
|
|
AAA/AA/A
|
2
|
|
BBB
|
3
|
|
BB
|
4
|
|
B
|
5
|
|
CCC and lower
|
6
|
|
In or near default
|
NAIC designation
|
|
Amortized cost
|
|
Estimated fair value
|
|
Percentage of total estimated fair value
|
|||||
1
|
|
$
|
9,603.4
|
|
|
$
|
10,582.6
|
|
|
47.9
|
%
|
2
|
|
9,571.6
|
|
|
10,526.7
|
|
|
47.7
|
|
||
Total NAIC 1 and 2 (investment grade)
|
|
19,175.0
|
|
|
21,109.3
|
|
|
95.6
|
|
||
3
|
|
617.6
|
|
|
622.9
|
|
|
2.8
|
|
||
4
|
|
237.2
|
|
|
240.7
|
|
|
1.1
|
|
||
5
|
|
83.5
|
|
|
82.7
|
|
|
.4
|
|
||
6
|
|
15.6
|
|
|
15.8
|
|
|
.1
|
|
||
Total NAIC 3, 4, 5 and 6 (below-investment grade)
|
|
953.9
|
|
|
962.1
|
|
|
4.4
|
|
||
|
|
$
|
20,128.9
|
|
|
$
|
22,071.4
|
|
|
100.0
|
%
|
|
Carrying value
|
|
Percent of fixed maturities
|
|
Gross unrealized losses
|
|
Percent of gross unrealized losses
|
||||||
Asset-backed securities
|
$
|
2,843.4
|
|
|
12.9
|
%
|
|
$
|
3.9
|
|
|
5.4
|
%
|
States and political subdivisions
|
2,070.7
|
|
|
9.4
|
|
|
2.5
|
|
|
3.4
|
|
||
Utilities
|
1,641.6
|
|
|
7.4
|
|
|
.7
|
|
|
.9
|
|
||
Healthcare/pharmaceuticals
|
1,596.1
|
|
|
7.2
|
|
|
2.7
|
|
|
3.8
|
|
||
Insurance
|
1,510.5
|
|
|
6.8
|
|
|
1.1
|
|
|
1.5
|
|
||
Energy
|
1,485.8
|
|
|
6.7
|
|
|
13.2
|
|
|
18.1
|
|
||
Commercial mortgage-backed securities
|
1,387.4
|
|
|
6.3
|
|
|
14.8
|
|
|
20.3
|
|
||
Banks
|
1,086.5
|
|
|
4.9
|
|
|
.2
|
|
|
.3
|
|
||
Food/beverage
|
970.3
|
|
|
4.4
|
|
|
.2
|
|
|
.3
|
|
||
Collateralized mortgage obligations
|
862.1
|
|
|
3.9
|
|
|
1.2
|
|
|
1.7
|
|
||
Cable/media
|
803.7
|
|
|
3.7
|
|
|
9.2
|
|
|
12.7
|
|
||
Real estate/REITs
|
593.5
|
|
|
2.7
|
|
|
.1
|
|
|
.1
|
|
||
Capital goods
|
546.5
|
|
|
2.5
|
|
|
.8
|
|
|
1.1
|
|
||
Chemicals
|
502.6
|
|
|
2.3
|
|
|
4.9
|
|
|
6.8
|
|
||
Transportation
|
472.6
|
|
|
2.1
|
|
|
.9
|
|
|
1.2
|
|
||
Telecom
|
430.4
|
|
|
2.0
|
|
|
1.8
|
|
|
2.5
|
|
||
Brokerage
|
350.4
|
|
|
1.6
|
|
|
.7
|
|
|
.9
|
|
||
Aerospace/defense
|
298.0
|
|
|
1.4
|
|
|
—
|
|
|
—
|
|
||
Technology
|
291.9
|
|
|
1.3
|
|
|
1.1
|
|
|
1.5
|
|
||
Autos
|
289.3
|
|
|
1.3
|
|
|
.6
|
|
|
.9
|
|
||
Business services
|
265.0
|
|
|
1.2
|
|
|
3.1
|
|
|
4.3
|
|
||
Paper
|
245.0
|
|
|
1.1
|
|
|
—
|
|
|
—
|
|
||
Collateralized debt obligations
|
227.4
|
|
|
1.0
|
|
|
—
|
|
|
—
|
|
||
Retail
|
213.4
|
|
|
1.0
|
|
|
1.4
|
|
|
1.9
|
|
||
Other
|
1,087.3
|
|
|
4.9
|
|
|
7.5
|
|
|
10.4
|
|
||
Total fixed maturities, available for sale
|
$
|
22,071.4
|
|
|
100.0
|
%
|
|
$
|
72.6
|
|
|
100.0
|
%
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Fixed maturity securities, available for sale:
|
|
|
|
|
|
|
|
||||||||
Gross realized gains on sale
|
$
|
21.1
|
|
|
$
|
21.3
|
|
|
$
|
28.1
|
|
|
$
|
119.8
|
|
Gross realized losses on sale
|
(5.2
|
)
|
|
(.6
|
)
|
|
(7.9
|
)
|
|
(81.6
|
)
|
||||
Impairments:
|
|
|
|
|
|
|
|
||||||||
Total other-than-temporary impairment losses
|
(3.6
|
)
|
|
—
|
|
|
(6.8
|
)
|
|
(6.3
|
)
|
||||
Other-than-temporary impairment losses recognized in accumulated other comprehensive income
|
(.9
|
)
|
|
—
|
|
|
(.9
|
)
|
|
—
|
|
||||
Net impairment losses recognized
|
(4.5
|
)
|
|
—
|
|
|
(7.7
|
)
|
|
(6.3
|
)
|
||||
Net realized investment gains from fixed maturities
|
11.4
|
|
|
20.7
|
|
|
12.5
|
|
|
31.9
|
|
||||
Equity securities
|
—
|
|
|
4.0
|
|
|
1.9
|
|
|
4.1
|
|
||||
Commercial mortgage loans
|
—
|
|
|
—
|
|
|
1.0
|
|
|
—
|
|
||||
Impairments of other investments
|
(.6
|
)
|
|
(13.6
|
)
|
|
(5.8
|
)
|
|
(17.3
|
)
|
||||
Loss on dissolution of variable interest entities
|
(3.7
|
)
|
|
(7.3
|
)
|
|
(3.7
|
)
|
|
(7.3
|
)
|
||||
Other (a)
|
8.1
|
|
|
8.8
|
|
|
17.2
|
|
|
.3
|
|
||||
Net realized investment gains
|
$
|
15.2
|
|
|
$
|
12.6
|
|
|
$
|
23.1
|
|
|
$
|
11.7
|
|
(a)
|
Changes in the estimated fair value of trading securities that we have elected the fair value option (and are still held as of the end of the respective periods) was
$9.9 million
for the
six
months ended
June 30, 2017
. Such amount was insignificant in the
2016
period.
|
|
Amortized
cost
|
|
Estimated
fair
value
|
||||
|
(Dollars in millions)
|
||||||
Due in one year or less
|
$
|
78.1
|
|
|
$
|
78.0
|
|
Due after one year through five years
|
118.5
|
|
|
116.8
|
|
||
Due after five years through ten years
|
174.8
|
|
|
166.3
|
|
||
Due after ten years
|
835.0
|
|
|
792.6
|
|
||
Subtotal
|
1,206.4
|
|
|
1,153.7
|
|
||
Structured securities
|
1,104.5
|
|
|
1,084.6
|
|
||
Total
|
$
|
2,310.9
|
|
|
$
|
2,238.3
|
|
|
Number
of issuers |
|
Cost
basis |
|
Unrealized
loss |
|
Estimated
fair value |
||||||
Less than 6 months
|
1
|
|
$
|
13.6
|
|
|
$
|
(3.5
|
)
|
|
$
|
10.1
|
|
Greater than 12 months
|
1
|
|
.7
|
|
|
(.2
|
)
|
|
.5
|
|
|||
|
|
|
$
|
14.3
|
|
|
$
|
(3.7
|
)
|
|
$
|
10.6
|
|
|
Investment grade
|
|
Below-investment grade
|
|
|
||||||||||||||
|
AAA/AA/A
|
|
BBB
|
|
BB
|
|
B+ and
below
|
|
Total gross
unrealized
losses |
||||||||||
Commercial mortgage-backed securities
|
$
|
12.9
|
|
|
$
|
.8
|
|
|
$
|
1.1
|
|
|
$
|
—
|
|
|
$
|
14.8
|
|
Energy
|
.2
|
|
|
6.6
|
|
|
3.9
|
|
|
2.5
|
|
|
13.2
|
|
|||||
Cable/media
|
.1
|
|
|
6.4
|
|
|
2.7
|
|
|
—
|
|
|
9.2
|
|
|||||
Chemicals
|
—
|
|
|
.6
|
|
|
4.3
|
|
|
—
|
|
|
4.9
|
|
|||||
Asset-backed securities
|
.8
|
|
|
1.7
|
|
|
.2
|
|
|
1.2
|
|
|
3.9
|
|
|||||
Business services
|
—
|
|
|
—
|
|
|
3.1
|
|
|
—
|
|
|
3.1
|
|
|||||
Healthcare/pharmaceuticals
|
.6
|
|
|
1.2
|
|
|
—
|
|
|
.9
|
|
|
2.7
|
|
|||||
States and political subdivisions
|
1.3
|
|
|
1.2
|
|
|
—
|
|
|
—
|
|
|
2.5
|
|
|||||
Building materials
|
—
|
|
|
.9
|
|
|
1.1
|
|
|
—
|
|
|
2.0
|
|
|||||
Telecom
|
—
|
|
|
.7
|
|
|
1.1
|
|
|
—
|
|
|
1.8
|
|
|||||
Retail
|
—
|
|
|
—
|
|
|
—
|
|
|
1.4
|
|
|
1.4
|
|
|||||
Collateralized mortgage obligations
|
.7
|
|
|
.1
|
|
|
—
|
|
|
.4
|
|
|
1.2
|
|
|||||
Technology
|
—
|
|
|
1.0
|
|
|
—
|
|
|
.1
|
|
|
1.1
|
|
|||||
Metals and mining
|
—
|
|
|
—
|
|
|
1.1
|
|
|
—
|
|
|
1.1
|
|
|||||
Insurance
|
—
|
|
|
1.1
|
|
|
—
|
|
|
—
|
|
|
1.1
|
|
|||||
Transportation
|
—
|
|
|
.9
|
|
|
—
|
|
|
—
|
|
|
.9
|
|
|||||
Capital goods
|
.1
|
|
|
.5
|
|
|
.2
|
|
|
—
|
|
|
.8
|
|
|||||
Brokerage
|
—
|
|
|
—
|
|
|
—
|
|
|
.7
|
|
|
.7
|
|
|||||
Utilities
|
.4
|
|
|
.1
|
|
|
—
|
|
|
.2
|
|
|
.7
|
|
|||||
Autos
|
—
|
|
|
.6
|
|
|
—
|
|
|
—
|
|
|
.6
|
|
|||||
Entertainment/hotels
|
—
|
|
|
.5
|
|
|
—
|
|
|
—
|
|
|
.5
|
|
|||||
Banks
|
.1
|
|
|
.1
|
|
|
—
|
|
|
—
|
|
|
.2
|
|
|||||
Food/beverage
|
—
|
|
|
.2
|
|
|
—
|
|
|
—
|
|
|
.2
|
|
|||||
Debt securities issued by foreign governments
|
—
|
|
|
.1
|
|
|
—
|
|
|
—
|
|
|
.1
|
|
|||||
Real estate/REITs
|
—
|
|
|
.1
|
|
|
—
|
|
|
—
|
|
|
.1
|
|
|||||
Other
|
2.3
|
|
|
.1
|
|
|
1.3
|
|
|
.1
|
|
|
3.8
|
|
|||||
Total fixed maturities, available for sale
|
$
|
19.5
|
|
|
$
|
25.5
|
|
|
$
|
20.1
|
|
|
$
|
7.5
|
|
|
$
|
72.6
|
|
|
|
Less than 12 months
|
|
12 months or greater
|
|
Total
|
||||||||||||||||||
Description of securities
|
|
Fair
value
|
|
Unrealized
losses
|
|
Fair
value
|
|
Unrealized
losses
|
|
Fair
value
|
|
Unrealized
losses
|
||||||||||||
United States Treasury securities and obligations of United States government corporations and agencies
|
|
$
|
47.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
47.0
|
|
|
$
|
—
|
|
States and political subdivisions
|
|
68.8
|
|
|
(2.0
|
)
|
|
13.2
|
|
|
(.5
|
)
|
|
82.0
|
|
|
(2.5
|
)
|
||||||
Debt securities issued by foreign governments
|
|
15.7
|
|
|
(.1
|
)
|
|
—
|
|
|
—
|
|
|
15.7
|
|
|
(.1
|
)
|
||||||
Corporate securities
|
|
566.2
|
|
|
(11.7
|
)
|
|
442.8
|
|
|
(38.4
|
)
|
|
1,009.0
|
|
|
(50.1
|
)
|
||||||
Asset-backed securities
|
|
388.6
|
|
|
(2.5
|
)
|
|
83.3
|
|
|
(1.4
|
)
|
|
471.9
|
|
|
(3.9
|
)
|
||||||
Collateralized debt obligations
|
|
30.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
30.5
|
|
|
—
|
|
||||||
Commercial mortgage-backed securities
|
|
381.5
|
|
|
(9.2
|
)
|
|
103.3
|
|
|
(5.6
|
)
|
|
484.8
|
|
|
(14.8
|
)
|
||||||
Collateralized mortgage obligations
|
|
69.3
|
|
|
(.7
|
)
|
|
28.1
|
|
|
(.5
|
)
|
|
97.4
|
|
|
(1.2
|
)
|
||||||
Total fixed maturities, available for sale
|
|
$
|
1,567.6
|
|
|
$
|
(26.2
|
)
|
|
$
|
670.7
|
|
|
$
|
(46.4
|
)
|
|
$
|
2,238.3
|
|
|
$
|
(72.6
|
)
|
Equity securities
|
|
$
|
134.2
|
|
|
$
|
(2.7
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
134.2
|
|
|
$
|
(2.7
|
)
|
|
Par
value
|
|
Amortized
cost
|
|
Estimated
fair value
|
||||||
Below 4 percent
|
$
|
2,046.0
|
|
|
$
|
1,589.5
|
|
|
$
|
1,642.5
|
|
4 percent – 5 percent
|
1,708.9
|
|
|
1,561.0
|
|
|
1,629.1
|
|
|||
5 percent – 6 percent
|
1,580.1
|
|
|
1,426.8
|
|
|
1,516.2
|
|
|||
6 percent – 7 percent
|
313.6
|
|
|
284.4
|
|
|
301.6
|
|
|||
7 percent – 8 percent
|
51.1
|
|
|
51.5
|
|
|
61.1
|
|
|||
8 percent and above
|
169.8
|
|
|
169.4
|
|
|
172.1
|
|
|||
Total structured securities
|
$
|
5,869.5
|
|
|
$
|
5,082.6
|
|
|
$
|
5,322.6
|
|
|
|
|
Estimated fair value
|
|||||||
Type
|
Amortized
cost
|
|
Amount
|
|
Percent
of fixed
maturities
|
|||||
Pass-throughs, sequential and equivalent securities
|
$
|
636.2
|
|
|
$
|
690.6
|
|
|
3.1
|
%
|
Planned amortization classes, target amortization classes and accretion-directed bonds
|
112.7
|
|
|
127.7
|
|
|
.6
|
|
||
Commercial mortgage-backed securities
|
1,364.7
|
|
|
1,387.4
|
|
|
6.3
|
|
||
Asset-backed securities
|
2,698.3
|
|
|
2,843.4
|
|
|
12.9
|
|
||
Collateralized debt obligations
|
226.1
|
|
|
227.4
|
|
|
1.0
|
|
||
Other
|
44.6
|
|
|
46.1
|
|
|
.2
|
|
||
Total structured securities
|
$
|
5,082.6
|
|
|
$
|
5,322.6
|
|
|
24.1
|
%
|
|
|
|
Estimated fair
value
|
||||||||
Loan-to-value ratio (a)
|
Carrying value
|
|
Mortgage loans
|
|
Collateral
|
||||||
Less than 60%
|
$
|
909.2
|
|
|
$
|
930.5
|
|
|
$
|
2,241.3
|
|
60% to 70%
|
465.9
|
|
|
467.4
|
|
|
714.7
|
|
|||
Greater than 70% to 80%
|
267.8
|
|
|
276.7
|
|
|
364.4
|
|
|||
Greater than 80% to 90%
|
37.6
|
|
|
38.7
|
|
|
43.7
|
|
|||
Greater than 90%
|
54.2
|
|
|
54.8
|
|
|
57.1
|
|
|||
Total
|
$
|
1,734.7
|
|
|
$
|
1,768.1
|
|
|
$
|
3,421.2
|
|
(a)
|
Loan-to-value ratios are calculated as the ratio of: (i) the carrying value of the commercial mortgage loans; to (ii) the estimated fair value of the underlying collateral.
|
|
Three months ended
|
|
Six months ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Net investment income – policyholder and other special-purpose portfolios
|
$
|
17.0
|
|
|
$
|
19.8
|
|
|
$
|
36.9
|
|
|
$
|
37.7
|
|
Fee revenue and other income
|
1.2
|
|
|
1.3
|
|
|
2.8
|
|
|
3.0
|
|
||||
Total revenues
|
18.2
|
|
|
21.1
|
|
|
39.7
|
|
|
40.7
|
|
||||
Expenses:
|
|
|
|
|
|
|
|
||||||||
Interest expense
|
13.3
|
|
|
13.5
|
|
|
26.9
|
|
|
26.0
|
|
||||
Other operating expenses
|
.6
|
|
|
.4
|
|
|
.9
|
|
|
.8
|
|
||||
Total expenses
|
13.9
|
|
|
13.9
|
|
|
27.8
|
|
|
26.8
|
|
||||
Income before net realized investment losses and income taxes
|
4.3
|
|
|
7.2
|
|
|
11.9
|
|
|
13.9
|
|
||||
Net realized investment losses
|
(3.9
|
)
|
|
—
|
|
|
(1.8
|
)
|
|
(6.4
|
)
|
||||
Income before income taxes
|
$
|
.4
|
|
|
$
|
7.2
|
|
|
$
|
10.1
|
|
|
$
|
7.5
|
|
|
Carrying value
|
|
Percent
of fixed
maturities
|
|
Gross
unrealized
losses
|
|
Percent of
gross
unrealized
losses
|
||||||
Healthcare/pharmaceuticals
|
$
|
160.7
|
|
|
12.3
|
%
|
|
$
|
.3
|
|
|
5.7
|
%
|
Cable/media
|
154.1
|
|
|
11.8
|
|
|
.4
|
|
|
6.4
|
|
||
Technology
|
140.5
|
|
|
10.7
|
|
|
.3
|
|
|
5.5
|
|
||
Food/beverage
|
90.9
|
|
|
6.9
|
|
|
.7
|
|
|
12.4
|
|
||
Capital goods
|
85.6
|
|
|
6.5
|
|
|
.3
|
|
|
5.7
|
|
||
Consumer products
|
70.7
|
|
|
5.4
|
|
|
.4
|
|
|
8.0
|
|
||
Aerospace/defense
|
56.8
|
|
|
4.3
|
|
|
.2
|
|
|
3.9
|
|
||
Paper
|
53.9
|
|
|
4.1
|
|
|
.1
|
|
|
1.0
|
|
||
Brokerage
|
53.6
|
|
|
4.1
|
|
|
—
|
|
|
.2
|
|
||
Building materials
|
50.5
|
|
|
3.8
|
|
|
.1
|
|
|
1.0
|
|
||
Retail
|
47.9
|
|
|
3.7
|
|
|
2.5
|
|
|
45.7
|
|
||
Autos
|
37.2
|
|
|
2.8
|
|
|
—
|
|
|
.2
|
|
||
Chemicals
|
34.5
|
|
|
2.6
|
|
|
—
|
|
|
.7
|
|
||
Utilities
|
33.9
|
|
|
2.6
|
|
|
.1
|
|
|
.8
|
|
||
Gaming
|
31.7
|
|
|
2.4
|
|
|
—
|
|
|
.7
|
|
||
Transportation
|
29.7
|
|
|
2.3
|
|
|
—
|
|
|
.5
|
|
||
Entertainment/hotels
|
29.5
|
|
|
2.3
|
|
|
—
|
|
|
.1
|
|
||
Insurance
|
23.4
|
|
|
1.8
|
|
|
—
|
|
|
.1
|
|
||
Metals and mining
|
15.7
|
|
|
1.2
|
|
|
—
|
|
|
—
|
|
||
Business services
|
13.0
|
|
|
1.0
|
|
|
—
|
|
|
.1
|
|
||
Real estate/REITs
|
13.0
|
|
|
1.0
|
|
|
—
|
|
|
.1
|
|
||
Banks
|
9.9
|
|
|
.8
|
|
|
—
|
|
|
—
|
|
||
Telecom
|
5.4
|
|
|
.4
|
|
|
—
|
|
|
.4
|
|
||
Energy
|
3.4
|
|
|
.3
|
|
|
—
|
|
|
.1
|
|
||
Textiles
|
.7
|
|
|
.1
|
|
|
—
|
|
|
—
|
|
||
Other
|
63.4
|
|
|
4.8
|
|
|
—
|
|
|
.7
|
|
||
Total
|
$
|
1,309.6
|
|
|
100.0
|
%
|
|
$
|
5.4
|
|
|
100.0
|
%
|
|
Amortized
cost
|
|
Estimated
fair
value
|
||||
|
(Dollars in millions)
|
||||||
Due in one year or less
|
$
|
2.1
|
|
|
$
|
2.0
|
|
Due after one year through five years
|
147.8
|
|
|
145.7
|
|
||
Due after five years through ten years
|
204.4
|
|
|
201.2
|
|
||
Total
|
$
|
354.3
|
|
|
$
|
348.9
|
|
|
|
|
At date of sale
|
||||||
|
Number
of issuers |
|
Amortized cost
|
|
Fair value
|
||||
Less than 6 months prior to sale
|
2
|
|
$
|
2.8
|
|
|
$
|
1.8
|
|
|
Number
of issuers |
|
Cost
basis |
|
Unrealized
loss |
|
Estimated
fair value |
||||||
Less than 6 months
|
1
|
|
$
|
5.4
|
|
|
$
|
(1.9
|
)
|
|
$
|
3.5
|
|
Period
|
|
Total number of shares (or units)
|
|
Average price paid per share (or unit)
|
|
Total number of shares (or units) purchased as part of publicly announced plans or programs
|
|
Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs (a)
|
||||||
|
|
|
|
|
|
|
|
(dollars in millions)
|
||||||
April 1 through April 30
|
|
1,085,885
|
|
|
$
|
20.70
|
|
|
1,085,885
|
|
|
$
|
187.2
|
|
May 1 through May 31
|
|
1,147,405
|
|
|
20.73
|
|
|
1,109,224
|
|
|
464.2
|
|
||
June 1 through June 30
|
|
1,148,448
|
|
|
20.43
|
|
|
1,147,785
|
|
|
440.8
|
|
||
Total
|
|
3,381,738
|
|
|
20.62
|
|
|
3,342,894
|
|
|
440.8
|
|
(a)
|
In May 2011, the Company announced a securities repurchase program of up to
$100.0 million
. In February 2012, June 2012, December 2012, December 2013, November 2014, November 2015 and May 2017, the Company's Board of Directors approved, in aggregate, an additional
$1,900.0 million
to repurchase the Company's outstanding securities.
|
10.1
|
Amendment effective May 16, 2017 to Employment Agreement between CNO Financial Group, Inc. and Edward J. Bonach.
|
|
|
12.1
|
Computation of Ratio of Earnings to Fixed Charges.
|
|
|
31.1
|
Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101.INS
|
XBRL Instance Document.
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document.
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
By:
|
/s/ John R. Kline
|
|
|
John R. Kline
|
|
|
Senior Vice President and Chief Accounting Officer
|
|
|
(authorized officer and principal accounting officer)
|
1.
|
Section 2 of the Agreement is hereby amended solely to change the ending date of the Term from October 1, 2017 to December 31, 2017. All other provisions of Section 2 of the Agreement shall remain unchanged.
|
2.
|
All provisions of the Agreement not amended hereby shall remain in full force and effect.
|
By:
|
/s/ Susan L. Menzel
|
|
Susan L. Menzel, Executive Vice
|
|
President, Human Resources
|
|
/s/ Edward J. Bonach
|
|
Edward J. Bonach
|
|
|
|
Six months
|
|
|
||||
|
ended
|
|
Year ended
|
||||
|
June 30,
|
|
December 31,
|
||||
|
2017
|
|
2016
|
||||
Pretax income from operations:
|
|
|
|
||||
Net income
|
$
|
145.7
|
|
|
$
|
358.2
|
|
Add income tax expense (benefit)
|
79.5
|
|
|
(5.0
|
)
|
||
Pretax income from operations
|
225.2
|
|
|
353.2
|
|
||
Add fixed charges:
|
|
|
|
||||
Interest expense on corporate debt
|
23.1
|
|
|
45.8
|
|
||
Interest expense on investment borrowings and borrowings related to variable interest entities
|
39.1
|
|
|
70.6
|
|
||
Interest added to policyholder account balances
|
53.3
|
|
|
112.9
|
|
||
Portion of rental (a)
|
9.2
|
|
|
17.2
|
|
||
Fixed charges
|
124.7
|
|
|
246.5
|
|
||
Adjusted earnings
|
$
|
349.9
|
|
|
$
|
599.7
|
|
Ratio of earnings to fixed charges
|
2.81X
|
|
|
2.43X
|
|
(a)
|
Interest portion of rental is estimated to be 33 percent.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of CNO Financial Group, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of CNO Financial Group, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|